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ABSTRACT 
African swine fever (ASF) is a devastating disease for which there is no vaccine 
available. The ASF virus (ASFV) primarily infects cells of the myeloid lineage and 
this tropism is thought to be crucial for disease pathogenesis. A detailed in vitro 
characterization of the interactions of a virulent (22653/14) and a tissue culture 
adapted (BA71V) strains of ASFV with porcine monocytes, un-activated (moM), 
classically (moM1) and alternatively (moM2) activated monocyte-derived 
macrophages was conducted to better understand this relationship. Low 
concentration of hM-CSF was selected as the method of choice to generate moM. 
Using a multiplicity-of-infection (MOI) of 1, both viruses were able to infect 
monocytes and macrophage subsets, but BA71V presented a reduced ability to infect 
moM1 compared to 22653/14, with higher expression of early compared to late 
proteins. Using an MOI of 0.01, only 22653/14 was able to replicate in all the 
macrophage subsets, with initially lowest in moM1 and moM2 ASFV down-
regulated CD16 expression and BA71V-infected but not 22653/14-infected moM 
and moM2 presented with a reduced expression of MHC class I. Higher levels of IL-
18, IL1- and IL-1 were released from moM1 after infection with BA71V. These 
results revealed differences between these strains, suggesting that virulent isolates 
have evolved mechanisms to counteract activated macrophages responses, promoting 
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CHAPTER 1. INTRODUCTION 
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1.1 Monocytes and macrophages  
 
Monocytes and macrophages are the main target of the African Swine Fever Virus 
(ASFV) (Sánchez-Cordón et al., 2008). 
Monocytes are primary immune cells, which are derived from a common myeloid 
progenitor cells in the bone marrow (haematopoietic stem cell) and there undergo 
differentiation steps, in response to macrophage colony-stimulating factor, before 
enter the bloodstream (Volkman and Gowans, 1965, Mosser and Edwards, 2008). In 
mice, monocytes can also be differentiated into 2 populations: ‘inflammatory’ 
monocytes, with a GR1+CX3CR1
low phenotype, which rapidly exit the blood, and 
‘resident’ monocytes, which do not express GR1− (Geissman et al., 2003). As shown 
in fugure 1.1, monocytes circulate in the peripheral blood before migrating to 
different tissues and replenish the tissue macrophage populations (Volkman and 
Gowans, 1965; Mosser and Edwards, 2008). Their half life is very short, about one 
day in mice (Van Furth and Cohn, 1968) and 3 days in humans (Whitelaw, 1972).  
 
 
Figure 1.1. Monocytes origin and differentiation. Monocytes originate in the bone 
marrow from a common haematopoietic stem cell (HSC) and there they undergo 
differentiation steps during which they commit to the myeloid and then to a 
monocyte lineage. They differentiate into monoblasts and then pro-monocytes before 
becoming monocytes, which enter the bloodstream. In mice these cells can 
differentiated into two populations: inflammatory and resident monocytes. It is 
unclear if inflammatory monocytes mature into resident monocytes or if they 
represent distinct populations. Monocytes migrate to different tissues, where they 
replenish tissue-specific macrophages. CNS, central nervous system; GM-CFU, 
granulocyte-macrophage colony-forming unit; M-CFU, macrophage colony-forming 
unit. Figure taken from Mosser and Edwards, 2008. 
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Monocytes are a heterogeneous population and in human they can be divided into 
two subsets: CD14+CD16- (90% of circulating monocytes), which are often called 
classical monocytes, and CD14+CD16+, which exhibit features of tissue macrophages 
(Ziegler-Heitbrock, 1996). CD14+CD16+ express CD32 and higher amount of MHC 
II molecules than classical monocytes and they have distinct chemokine–receptor 
expression profile (Weber et al., 2000). Human monocytes can also be characterised 
also by their expression of CD64, also known as FcyRI (Grage-Gribenow et al., 
2001). CD14+CD16+CD64+ monocytes present a dendritic cells (DC) phenotype, 
expressing higher levels of MHC II and CD80/86 than classic monocytes and having 
an enhanced T-cell-stimulatory activity (Grage-Gribenow et al., 2001). It was 
speculated that CD14+CD16+CD64+ cells could represent an immunoregulatory 
monocyte phenotype or an intermediate phenotype between monocytes and DC 
(Grage-Gribenow et al., 2001). As previously stated, in mice monocytes can be 
divided according to their expression of CCR2, CX3C-chemokine receptor 1 
(CX3CR1) and GR1 into two subpopulations: inflammatory CCR2+GR1+CX3CR1low 
and resident CCR2-GR1-CX3CR1high (Palfrarman, 2001, Geissman et al., 2003). It is 
unclear if they represent distinct populations or if inflammatory monocytes are 
initially released into the circulation and, in the absence of inflammation, they 
mature into resident macrophages, altering their functional and phenotypic 
characteristic, passing through an intermediate phenotype (CCR2+GR1low) (Gordon 
and Taylor, 2005). Porcine monocytes can instead be characterised based on 
expression of CD163, which is scavenger receptor of haemoglobin/haptoglobin 
complexes (Sachez et al., 1999, Kristiansen et al., 2001). CD163+ monocytes 
represent a more mature subset, in fact they produce higher amount of TNF-, 
present higher levels of CD80/CD86 co-stimulatory molecules and SLA DR antigens 
and have better antigen-presenting capacity to primed T CD4+ lymphocytes 
(Chamorro et al., 2004).  
As shown in figure 1.1, circulating monocytes migrate into tissue in the steady state 
or in response to inflammation, where they differentiate into macrophages or into 
specialised cells such as DC and osteoclasts (Volkman and Gowans 1965, Mosser 
and Edwards, 2008). Beyond this precursor role, monocytes can carry out specific 
effector functions during infection (Serbina et al., 2008). In fact in mice 
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inflammatory monocytes are implicated in defence against bacterial, protozoal, and 
fungal pathogens. They respond rapidly to microbial stimuli by secreting cytokines 
and antimicrobial factors (Serbina, et al., 2008). In addition, a recent study reported 
that in mice monocytes can participate in steady-state surveillance of the lung, in a 
complementary way to resident macrophages and DC, without differentiating into 
macrophages (Rodero et al., 2015). 
Macrophages as recognised by Metchnikoff are first and foremost professional 
phagocytes, which express all the genes required to internalize particles and to 
degrade those particles in lysosomes (Hume, 2015). Tissue macrophages maintain 
tissue homeostasis though the clearance of senescent cells and the repair/remodelling 
of tissues after inflammation (Gordon, 1988). They clear the interstitial environment 
of extraneous cellular materials, independently of immune-cell signalling and in the 
absence of other immune cells. Macrophages are involved in removal of cellular 
debris that are generated during tissue remodelling and rapidly clear cells that have 
undergone apoptosis. In human they also clear approximately 2 x 10 erythrocytes 
each day, recovering iron and haemoglobin (Mosser and Edwards, 2008). These cells 
can rapidly respond to endogenous danger signals generated following injury or 
infection. They recognize pathogen-associated molecular patterns (PAMPs) through 
pattern-recognition receptors (PRRs), such as toll like receptors (TLRs), NOD-like 
receptors (NAPLs) and C-type lectin receptors. Through complement receptors these 
cells interact with the complement inflammatory cascade, crucial to ward off 
infection (Martinez et al., 2009). Macrophage are a heterogeneous population and 
this heterogeneity reflect the specialization of function adopted by macrophages in 
different anatomical locations. For example osteoclasts are specialised in bone 
remodelling and instead alveolar macrophages present high expression of pathogen 
recognition receptors (PRRs), enabling them to clear microorganisms, virus and 
environmental particles in the lung (Gordon and Taylor, 2005).  
In vitro human monocytes can be differentiated into macrophages (MoM with the 
addition of macrophage colony stimulator factor (M-CSF) to culture media (Gordon 
and Taylor, 2005). M-CSF, also known as colony-stimulating factor-1 (CSF-1), 
controls the survival, proliferation, and differentiation of mononuclear phagocytes 
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(Stanley et al., 1997). It drives the differentiation of monocytes into macrophages 
acting via a cell surface tyrosine kinase receptor, known as colony stimulating factor 
receptor 1 (CSF-1R), expressed on cells of the mononuclear phagocyte lineage 
(Stanley et al., 1997). CSF-1 bind to the CSF receptor (CSF-1R) and it has been 
reported that treatment of mice with monoclonal antibodies against this receptor 
depleted most tissue macrophage populations (McDonald et al., 2010).  
In pigs monocytes can be differentiated into macrophages through culture with M-
CSF for 4-7 days (Singleton et al., 2016, Kyrova et al., 2014) or with different 
concentration of porcine serum or plasma for 3-4 days (10%: Garcia-Nicolas et al., 
2014, Kyrova et al., 2014; 20% Chamorro et al., 2000, Sanchez-Torres et al., 2003; 
30%: McCullough et al., 1997, McCullough et al., 1999, Basta et al., 1999, Basta et 
al., 2001, Tsai et al., 2010). In addition, some authors used the media from the 
murine fibroblast L929 cells line as a source of M-CSF (Genovesi et al., 1990, Zsak 
et al., 1998, Wang et al., 2011). In few studies researchers differentiated monocytes 
into macrophages using media supplemented with just 10% fetal bovine serum (FBS) 
(10%: Gil et al., 2003, Gil et al., 2008), but the work of McCullough and colleagues 
(1999) reported that monocytes cultured in media supplemented with FSB remained 
morphologically closer to monocytes than those cultured in porcine plasma 
(McCullough et al., 1999). As previously stated, in humans M-CSF is commonly 
used to in vitro differentiate monocytes into macrophages (Gordon and Taylor, 2005) 
and treatment of porcine monocytes with M-CSF increases cell viability (Genovesi et 
al., 1990). Fairbairn et al. (2014) observed that porcine PBMC cultured with hM-
CSF (104 U/ml) increased in size and granularity compared with freshly isolated 
PBMC and that the CD14+CD172a+ population was selectively expanded, suggesting 
that as in humans M-CSF act as a mitogen for pig monocytes (Fairbairn et al., 2014). 
To date there is not a standardize protocol to in vitro differentiate porcine monocytes 
into macrophages and in the first part of this thesis we focus on comparing different 
methods described in the literature, assessing their effect on macrophages 
morphology, expression of surface markers, cytokine release and susceptibility to 
monocytropic ASFV (Chapter 3). 
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Several studies analyzed the interaction of ASFV with monocytes and macrophages, 
and there are better described in the section 1.7.1. To date, no studies investigated the 
interaction of ASFV with activated macrophages. 
Macrophages present remarkable plasticity, that allow them to respond to 
environmental signals, produced also by antigen-specific immune cells. Both the 
innate and the adaptive immune responses affect their phenotype and physiology 
(Mosser and Edwards, 2008). Macrophage activation results in their polarisation into 
different functional subsets: classical activated macrophages (M1), alternative 
activated macrophages (M2) and type II-activated or regulatory macrophages 
(Mosser, 2003, Mosser and Edwards, 2008), as represented in figure 1.2. 
M1 polarization can be reached in vitro by exposure to IFN- and lipopolysaccharide 
(LPS), which induces TNF production. Classical activation results in secretion of 
high levels of pro-inflammatory cytokines and increased microbicidal or tumoricidal 
capacity (Mosser, 2003). Stimulation with IFN- results in increased production of 
superoxide anions, oxygen and nitrogen radicals by macrophages. In fact the main 
role of M1 macrophages is in host defence to intracellular pathogens and in driving 
Th1 cellular immune responses (Mosser and Edwards, 2008). It was reported that 
mice lacking IFN- expression are more susceptible to various bacterial, protozoal 
and viral infections, as are humans with genetic mutations in these signalling 
pathways (Filipe-Santos et al., 2006). Moreover some pathogens have developed 
mechanisms to interfere with IFN- signalling and to prevent efficient macrophage 
activation (Mosser and Edwards, 2008). M1 are vital component of the host defence, 
but their activation might be tightly controlled, in fact they are key mediators of the 
immunopathology that occurs in several autoimmune diseases (Mosser and Edwards, 
2008). Very few studies analysed macrophage classical activation in pigs. It was 
reported that in pig classical activation led to MHC II up-regulation, suggesting that 
also in this specie M1 have and enhanced antigen presenting functions (Garcia-
Nicolas et al., 2014, Singleton et al., 2016).   
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Figure 1.2. Cytokines produced by immune cells can give rise to macrophages 
with distinct physiology. Classical activated macrophages arise in response to IFN-
, which can be produced by T cells or NK cells, and TNF, produced by antigen 
presenting cells (APCs). Alternative activated macrophages arise in response to IL-4, 
which can be produced by TH2 cells or by granulocytes. Regulatory macrophages 
are generated in response to various stimuli, such as immune complexes, 
prostaglandins, G-protein coupled receptor (GPCR) ligands, glucocorticoids, 
apoptotic cells or IL-10. Figure taken from Mosser and Edwards, 2008. 
Alternative activation of macrophages was discovered later than classical activation. 
It was found that alternative activation occurred via the stimulation of macrophages 
with IL-4, which was found to up-regulate expression of the mannose receptor 
(CD206) (Stein et al., 1992). Activation with this cytokine was clearly distinct from 
the classic activated macrophage, in fact M2 do not produce NO and have a poor 
ability to kill intracellular pathogens (Modolell et al., 1995). It was later discovered 
that alternative activation results also from exposure to IL-13, which shares the same 
IL-4 receptor alpha (IL-4Rα) chain as IL-4 (Gordon, 2003). M2 macrophages are 
primarily associated with mechanisms of immunosuppression and wound repair 
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(Gordon, 2003), in fact they are also called ‘wound-healing’ macrophages (Mosser 
and Edwards, 2008). They are not efficient at antigen presentation and instead 
promote cell growth, collagen formation and tissue repair; M2 secrete several 
fibrogenic factors and insulin-like growth factor 1 and platelet-derived growth factor 
C, which provide signals for tissue proliferation and repair (Mosser, 2003, Martinez 
et al., 2009). M2 produce high levels of the pro-inflammatory cytokine IL-10 and 
mediate repression of pro-inflammatory factors, so are compromised in their ability 
to kill intracellular pathogens and down-regulate a pro-TH1 response (Mosser, 2003, 
Martinez et al., 2009). Macrophage alternative activation is implicated in the success 
of TH2 responses, mainly directed toward extracellular parasites such as helminths 
and some protozoa. Intracellular pathogens have, as a result, created mechanism to 
promote macrophage alternative activation and to avoid TH1 immune control 
(Martinez et al., 2009). Very few studies analysed macrophage alternative activation 
in pigs. In this specie alternative activation leads to CD163 down-regulation, but has 
no influence on MHC class I or II expression (Garcia-Nicolas et al., 2014).   
Another macrophage category is the type II-activated macrophage, which were 
recently classified as one M2 subtype. In fact M2 can be subdivided in three 
subtypes: M2a (after exposure to IL-4 or IL-13), M2b (immune complexes in 
combination with IL-1beta or LPS) and M2c (IL-10, TGF-beta or glucocorticoids) 
(Martinez et al., 2008). Macrophage activation with immune complexes and LPS 
results in inhibition of IL-12 and promotion of IL-10 secretion, up-regulation of 
antigen presentation and promotion of a TH2 response (Martinez et al., 2008). 
Glucocorticoids affect monocyte adherence, spreading, phagocytosis and apoptosis, 
whereas IL-10 is a potent inhibitor of TH1 cells (Martinez et al., 2008). 
Nevertheless, macrophage taxonomy and the M1/M2 paradigm is a limited attempt 
to define the complexity and plasticity of mononuclear phagocytes. Individual 
macrophage cells differ markedly from each other, and change their functions in 
response to the subtle and continuous changes in the surrounding environmental 
signals, so M1/M2 subsets represent the two extreme of diverse functional 
macrophage activation states (Sica and Matovani, 2012, Italiani and Boraschi, 2014, 
Hume, 2015).  
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
1.2 African Swine Fever 
African swine fever (ASF) is caused by a highly infectious virus that affects 
domestic and wild pigs and it is considered a notifiable disease by the OIE World 
Organisation for Animal Health because of its potential for rapid dissemination and 
significant socio-economical consequences (Sanchez-Vizcaino, 2006). 
The aetiological agent is the African swine fever virus (ASFV), the only member of 
the Asfarviridae family (Dixton et al., 2005).  
ASF is currently endemic in many sub-Saharan countries of Africa and Sardinia 
(Italy). The spread of this disease to the Caucasus region in 2007, and from there to 
Russia and Ukraine in 2012, Belarus in 2013, and European Union countries 
(Lithuania, Estonia, Latvia and Poland) in 2014-2016, now endangers the pig 
industry worldwide (Alonso, 2013, OIE WAHIS interface).  
In Russia ASFV progressively spread and 18 federal districts reported outbreaks 
(OIE, WAHIS interface). In this area ASFV has been isolated in wild boars and the 
persistence of the virus in the sylvatic cycle makes eradication more difficult 
(Beltran-Alcrudo et al., 2008). In addition, a recent study revealed the existence of 
long-term infected animals in this area, which could become carriers and persist in 
the population, leading to the maintenance and future reappearance of the disease 
(Mur et al., 2016a).  
In Poland ASFV was first detected in early 2014 and between 2014 and 2015 65 
cases of ASFV infection in wild boar have been recognised, located near the border 
with Belarus in Sokółka and Białystok counties (Wozniakowski et al., 2016). 
Recently, in that country cases of ASFV have been described also in domestic pigs 
(OIE WAHIS interface). 
The distribution of ASFV from January 2016 is illustrated in Figure 1.3.  
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Figure 1.3 Distribution of ASFV from January 2016. Figure taken from 
http://web.oie.int (disease and distribution maps). 
 
Using retrospective analysis it was established that the first ASFV outbreak occurred 
in Africa in 1907, but the disease was firstly described in Kenia in 1921 by 
Montgomery. The first spread of ASF outside Africa was to Lisbon (Portugal) in 
1957 and a further outbreak occurred in 1960 in Lisbon. ASF become endemic in all 
the Iberian peninsula and outbreaks were reported subsequently in a number of other 
European countries, including Malta, Italy, France, Belgium and The Netherlands 
(Costard et al., 2013). In Spain and Portugal complete eradication took more than 30 
years (Sanchez-Vizcaino, 2006). 
In Sardinia the disease first occurred in 1978 and now is endemic, as a result of 
extensive pig farming that has been practised for centuries and of the presence of 
endemically infected wild boar (Firinu et al., 1988; Costard et al., 2009). 
There is no vaccine or treatment available and apart from stamping out and 
movement control, there are no control measures, thereby potentially resulting in 
extreme losses for producers (Costard et al., 2013). 
 
As previously written, ASF affects both domestic and wild pigs (Sanchez-Vizcaino, 
2006).  
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African wild pigs are resistant to the disease and ASF persists in Africa via a natural 
cycle of transmission between the warthog (Phacochoerus aethiopicus), bushpig 
(Potamchoerus porcus) and the soft tick (Ornithodorus moubata). Warthogs are born 
free from infection and may be infected early in life following the bite of an infected 
tick. Virus replicates in the warthog and produces a low degree of viraemia for a few 
weeks, which is sufficient to infect a proportion of ticks that feed on the viraemic 
young warthogs (Thomson, 1985). Domestic pigs in Africa acquire infection from 
wildlife reservoirs of the virus primarily by the bite of an infected tick (Plowright, 
1977). 
In other areas, such as Sardinia, infection can occur either directly (escretions, 
secretions, dead animals) or indirectly (fomites, such as clothing, equipment and 
vehicles), in fact ASFV can persist in the environment for several days. The virus 
can persist in tissues for several months and feeding domestic pigs with uncooked 
swill can result in infection (Costard et al., 2009). Soft ticks Ornithodoros are absent 
in Sardinia, so they are not involved in the persistence of the virus in the island 
(Costard et al., 2013). In a recent study 1767 porcine serum samples collected from 
all around the island (1261 from domestic and 506 from wild boar) were analysed for 
antibodies to salivary antigens of Ornithodoros erraticus and only one sample 
resulted positive. In addition, ticks were directly searched in a number of pig 
premises with no success, confirming the absence of Ornithodoros Erraticus tick role 
in ASF cycle in Sardinia (Mur et al., 2016b). 
Recovered pigs can remain persistently infected for periods of 6 months or more, 
representing an obstacle for eradication of the disease from endemic areas 
(Wilkinson 1984, Oura et al. 2005). 
The clinical signs associated with ASF are very varied as they depend on how 
virulent the viral isolate is and on the breed and physical condition of the pig. 
African ASFV isolates generally induce peracute or acute disease. European 
domestic pigs and boars are very susceptible and exhibit a wide range of clinical 
signs from subacute to chronic. As above stated, wild African pigs are very resistant 
to infection and do not generally present any lesions (Sánchez-Vizcaíno, 2006). 
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In Europe, it has been observed that wild boars are susceptible to the disease as 
domestic pigs (Jori and Bastos, 2009, McVicar et al., 1981). Outbreaks of ASF in 
wild boars fade out, so the contact with infected domestic pigs or other source of 
infection is essential for the persistence of the virus in the sylvatic cycle (Laddomada 
et al., 1994). 
In the acute form, the animals show high temperatures (40-42ºC), recumbency and 
lack of appetite, and suffer respiratory disorders. In some cases there may be nasal 
haemorrhaging, constipation and vomiting. Exanthemas are very evident (pinkish 
almost purple skin due to intense hyperaemia), and/or cyanotic foci, which appear as 
irregular purple-coloured marks on the skin of the extremities, ears, chest, abdomen 
and perineum. Abortion frequently occurs in gestating females. In acute cases, the 
disease causes death in 90 to 100% of affected animals. In acute and subacute 
courses death occurs between 7 and 20 day post infection, the signs develop more 
slowly. The chronic form is characterised by a large variety of clinical signs which 
are mainly the result of secondary bacterial complications. Mortality is low, affecting 
between 2 and 10% of all the sick animals (Sánchez-Vizcaíno, 2006).  
Some characteristic ASF lesions are: purplish and megalic spleen, haemorrhaging in 
the tonsils and lymphatic ganglia, particularly in the gastrohepatic and renal ganglia, 
and petechial haemorrhaging in the kidneys, bladder mucosa, pharynx and larynx, 
pleura and heart, endocardium and pericardium, hydropericardium, ascitis, and 
hydrothorax and hepatic congestion (Figures 1.4, 1.5, 1.6) (Sánchez-Vizcaíno, 2006). 
The disease is characterised by severe lymphopenia, immunodepression and 
thrombocytopenia (Gómez-Villamandos et al., 2013). 
 
  
Figure 1.4 Spleen: purplish and megalic (Sánchez-Vizcaíno, 2002). 
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
 
   
Figure 1.5 Tonsils with subepithelial haemorrhages (Sánchez-Vizcaíno, 2002).   
 
Figure 1.6 Kidney: petechiae in the entire cortex area (Sánchez-Vizcaíno, 2002).  
 
1.3 African Swine Fever Virus 
As above stated, the aetiological agent is the African swine fever virus (ASFV), the 
only member of the Asfarviridae family (Dixon et al., 2005). It is a large, enveloped 
virus with double-stranded DNA genome of 170 to 190 kbp. ASFV encodes for 
between 151 and 167 open reading frames (ORFs) (Dixon et al., 2013a).  
The ASFV particle has an icosahedral morphology with an average diameter of 200 
nm and is composed by several concentric domains, as illustrated in Figure 1.7: 1) an 
internal core, 2) the core shell, a thick protein layer, 3) an inner lipid envelope, 4) the 
icosahedral capsid (Carrascosa et al., 1984; Andres et al., 1997). The extracellular 
virions possess also an external envelope (Breese and DeBoer, 1966).  
Thanks to this structure, the virus is highly resistant to PH and temperature 
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ASFV is highly resistant to PH and temperature variations, in fact it remains stable at 
PH 4-10 and it is inactivated only after cooking for 20 minutes at 60°C. Smoked 
sausages and matured ham required smoking at 32-49°C for 12 hours and maturing 




Figure 1.7 Localization of different ASFV structural proteins inside ASFV 
(Figure taken from Salas and Andres, 2013). 
 
 
ASFV entry involves dynamin-dependent and clathrin-mediated endocytosis 
(Hernaez and Alonso, 2010) or through macropinocytosis (Sanchez et al., 2012). 
 
During endocytosis, ASFV viral particles undergo disassembly in various 
compartments, thanks to the acid pH of endosomes. In fact, the inhibition of the 
endosomal acidification impedes ASFV desencapsidation and so successful infection 
(Cuesta-Geijo et al., 2012). Then ASFV requires cholesterol to exit the endosome to 
gain access to the cytoplasm, in order to establish productive replication. In fact a 
recent study reported that accumulation of cholesterol in endosomes impairs fusion, 
resulting in retention of ASF virions inside endosomes (Cuesta-Geijo et al., 2015).  
After exit from the endosome-lysosome, ASFV virions develop a strong association 
with the microtubular network (Netherton and Wileman, 2013). One of the major 
structural proteins of ASFV, p54, interacts directly with the 8-kDa light chain of the 
microtubule motor protein dynein (Alonso et al., 2001) and it has been shown that 
alteration in the p54-dynein interaction in infected cells results in a marked decrease 
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in virus infectivity, viral replication and finally virus production (Hernaez et al., 
2010). 
 
ASFV DNA replication occurs mainly in perinuclear cytoplasmic viral assembly 
sites, close to the microtubular organizing centre (MTOC), known as virus factories 
(Netherton and Wileman, 2013). ASFV factories recruit different cellular 
components, including cellular chaperones, such as hsp70, and mitochondria 
(Castelló et al., 2009; Heath et al., 2001; Rojo et al., 1998). 
 
During ASFV infection, all the components of the translation machinery examined 
(eIF4G, eIF4E, eIF2, eIF3b and the eukaryotic elongation factor 2 [eEF2]) and 
ribosomes are relocated from a diffused distribution throughout the cytoplasm of 
infected cells to the viral factories. Also the mitochondria network are mobilized 
together with ribosomes to the viral factories. The increase in the availability of host 
sources in the viral factories and simultaneously its depletion in the cytoplasm may 
results in the shut off of the host mRNA translation (Castello et al., 2009).  
ASFV mRNAs are structurally similar to the cellular mRNAs and posses a cap 
structure in its 5’-UTR and a poly (A) tail of 33 nucleotides in average (Salas et al., 
1981). The fact that ASFV mRNAs are capped indicates that they drive translation 
by a canonical cap-dependent mechanism, as happens with most of cellular mRNAs. 
Also some studies reported that a part of the genome replication is initiated within 
the nucleus (Netherton and Wileman, 2013). 
ASFV utilises the cytoskeletal network to facilitate its egress from the virus factory 
to the plasma membrane and out of the infected cell (Netherton and Wileman, 2013). 
Finally progeny virions are bud out or are propelled away along actin projections to 
infect new cells (Netherton and Wileman, 2013). In fact, ASFV infection induces 
long unbranched actin projections, similar to those detected in filopodia, that 
originate from the plasma membrane (Jouvenet et al., 2006). Interestingly, ASFV 
infection evolves toward cell lysis at very late times of infection (Breese and 
DeBoer, 1966), which might represent an alternative mechanism of viral egress. 
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Figure 1.8 Replication cycle of ASFV. Replication cycle of ASFV, from virus entry 
to formation of the early endosome, its maturation, virion desencapsidation in the 
acidic late endosomal compartments and finally to virions exit along actin 
projections (Figure taken from Alonso et al., 2013). 
 
The first morphological indication of viral assembly is the accumulation within the 
factory of viral membranes, which are the precursors of the inner envelope of the 
viral particle (Salas and Andres, 2013). Then, the capsid is preassembled on the 
convex face of the viral membranes, which thus become polyhedral forms (Garcia-
Escudero et al., 1998). P72 is the major capsid protein, but capsid assembly depends 
also on protein pB602L, a non-structural protein that acts as a chaperone for the 
folding of p72 (Epifano et al., 2006a), and on protein pB438L, a minor capsid 
component probably involved in the formation of the capsid vertices (Epifano et al., 
2006b). 
Simultaneously to the capsid assembly, the core shell is formed underneath the 
concave face of the viral envelope (Andres et al., 1997) and its main constituents 
domain are the proteolytic products of the two virus polyproteins pp220 and pp62 
(Andres et al., 2002). 
The formation of the nucleoid is likely to be the last step in morphogenesis. Probably 
the viral DNA is first encapsidated, possibly together with nucleoproteins, and then 
condensed inside the assembling virus particles to produce the “full” mature virions 
(Salas and Andres, 2013). 
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African swine fever virus (ASFV), like other complex DNA viruses, sets up a 
number of strategies to evade the host’s defense systems, such as apoptosis, 
inflammation and immune responses (Sanchez et al., 2013). Some viral proteins 
involved in evading host’s defence are described below.  
 
ASFV proteins involved in modulating host defence, regulating host gene 
transcription, are: 
• A238L protein, which inhibits activation of the transcriptional factors NFkB 
and NFAT. It interacts with the p65 subunits of NFkB during infection, creating a 
complex thus inhibiting this transcriptional factor (Revilla et al., 1998). In addition, 
A238L alters the activity of NFAT, through inhibition of the host calcineurin 
dependent pathways (Dixon et al., 2004). This protein down-regulates the production 
of pro-inflammatory cytokines, such as TNF- by ASFV infected macrophages 
(Powell et al., 1996, Granja et al., 2006a). In fact it has been reported that infection 
with the mutant ASFV E70, deleted on A238L, is characterized by an increased 
synthesis of TNF- and other cytokines (Salguero et al., 2008). A238L has effects 
also on the nitric oxide synthesis. By using a recombinant ASFV lacking of the 
A238L gene, it has been demonstrated that A238L strongly down regulates inducible 
nitric oxide synthase (iNOS) activation (Granja et al., 2006b). 
• A224L protein, which is an inhibitor of apoptosis (Nogal et al., 2001) and is 
also involved in the NK-kB activation (Rodriguez et al., 2002). 
• ASFVj4R protein, which binds the host -NAC protein (Goatley et al., 2002) 
and influences its transcription. It has been speculated that the interaction between 
ASFVj4R and -NAC affects the ability of this cellular factor to act as a 
transcription co-activator (Sanchez et al., 2013).  
• The ASFV ubiquitin conjugating (UBCv) enzyme, which might play a role in 
regulating host gene transcritpion. In fact it was described that this viral protein  
binds the NH2-terminal end of a host nuclear protein SMCy, which is involved in 
gene transcription (Bulimo et al., 2000). 
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In addition ASFV developed mechanisms to regulate host cell cycle. ASFV strongly 
induces Myc activation from early times after infection, which promotes cell 
growing and protein synthesis (Castello et al., 2009). It regulates the expression of 
the components of eIF4F complex at transcriptional level, in order to guarantee the 
viral protein synthesis (Castello et al., 2009). Moreover it has been reported that the 
viral protein A224L inhibits caspase activation, promoting cell survival (Nogal et al., 
2001). 
 
This virus monopolizes all the components of the host translation machinery, 
relocating them to the ‘viral factories’, in order to guarantee viral proteins synthesis.  
The phosphorylation of the  subunit of the eIF2 inhibits its activity and so inhibits 
translation and protein synthesis, so eIF2 phosphorylation is one of the most 
important host defense mechanisms against viral infections and ASFV has developed 
mechanisms to avoid the phosphorylation of this factor (Sanchez et al., 2013). 
Phosphorilated-eIF2 levels decrease at early times post infection, and remain 
undetectable throughout the infection (Castello et al., 2009), suggesting a viral 
mechanism to ensure the availability of this factor for viral protein synthesis. 
It has been shown that DP71L induces a decrease of phosphorylated eIF2 and 
enhances the expression of co-transfected reporters, suggesting that DP71L plays a 
role in keeping the translation machinery active to allow viral protein synthesis 
(Zhang et al., 2010). However, ASFV possess multiple mechanisms to avoid eIF2 
phosphorylation (Zhang et al., 2010). It has been observed that this virus induces 
phosphorylation of eIF4E, which takes place after 8 hours post infection (pi) and is 
associated to an enhancement of the viral replication and protein synthesis (Castello 
et al., 2009). 
 
Moreover, ASFV encodes several proteins involved in inhibiting apoptosis of 
infected cells. In fact, ASFV-infected macrophages undergo apoptosis at late time 
post-infection (24-48 hours pi), suggesting that there are some viral genes that 
negatively regulate apoptosis (Ramiro-Ibanez et al., 1996), such as: 
• The protein encoded by A179L, which represents the viral homolog of the 
anti-apoptotic protein Bcl2 (vBcl2) and inhibits the action of several pro-
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apoptotic protein (Bid, BimL, BimS, BimEL, Bad, Bmf, Bik, Puma and DP5) 
(Galindo et al., 2008). 
• A224L protein, a homolog of inhibitor of apoptosis proteina (IAP), which 
inhibits caspase 3 (Nogal et al., 2001) and activates the transcription factor 
NFkB (Rodriguez et al., 2002). 
• E153 protein, which acts on the 53 pathway (Hurtado et al., 2004). 
• DP71L protein, which induces dephosphorylation of the initiator factor 
eIF2, playing an important role in keeping the translation machinery active 
to synthesize new viral proteins (Rivera et al., 2007, Zhang et al., 2010). 
 
Phylogenetic analysis of ASFV is based on the partial sequence of the B646L gene, 
which encodes for the structural protein p72 (Bastos et al., 2003). This analysis 
showed that is a strong correlation between isolates from West Africa, South 
America and Europe collected before 2007, all belonging to genotype I. In contrast, 
isolates from South and East Africa present more differences and are grouped in 
other 22 genotypes (Bastos et al., 2003, Lubisi et al., 2005, Boshoff et al., 2007, 
Achenbach et al., 2016). Genotype XXIII is present in Ethiopia and was only 
recently discovered (Achenbach et al., 2016). 
As previously stated, in June 2007 ASF was confirmed in Georgia, and it has since 
spread to neighboring countries. Sequence analysis indicated that the Georgia 2007 
isolate is closely related to isolates belonging to genotype II, which is circulating in 
Mozambique, Madagascar, and Zambia (Rowlands et al., 2008). ASFV was first 
detected in Russia 2007 and all the isolates collected in the Russian Federation from 
2007 to 2011 revealed 100% nucleotide identity of B646L gene sequence and formed 
one genetic cluster within genotype II (Malogolovkin et al., 2012). 
Other genes have been used to discriminate between isolates on a regional level: 
B602L (coding for the J9L protein), CP204 (coding for the P32 protein) and E183L 
(coding for the envelope protein P54) (Gallardo et al., 2009, Nix et al., 2006, 
Rowlands et al., 2008). The analysis of this genes is useful to study the epidemiology 
and evolution of different isolates and can be used to identify the source of 
contamination in case of new ASFV outbreaks (Nix et al., 2006). 
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Recently the analysis of the TRS in the intergenic region between the I73R and  
I329L genes, at the right end of the genome, has been used to investigate the genetic 
variability among ASFV isolates circulating in eastern Europe. Viruses from Poland 
and Lithuania presented a TRS insertion identical to that present in ASFV isolates 
from Belarus and Ukraine, but not in the remaining viruses from eastern Europe, 
including those obtained in Russia in 2012 and in Georgia in 2007. These molecular 
data suggested that the ASFV isolstes detected in Poland and Lithuania most 
probably originated from Belarus (Gallardo et al., 2014).   
 
The phylogenetic analysis, based on the sequence of the gene coding for the protein 
p72, showed that all the Sardinian isolates belong to the genotype I, along with the 
isolated from South America, Caribbean, West Africa and Europe (Giammaroli et 
al.,  2011). Between Sardinian isolates there are no differences in the genomic region 
p54, but there are differences in the B602L gene, which is involved in viral 
morphogenesis. Sardinian isolated can be divided in two subgroups (X and III) on 
the basis of the presence/absense of a deletion of 12-13 tetramers in this region. This 
deletion (subgroup X) is present in almost all the isolates from 1990 and there are no 
differences between viruses isolated from domestic pigs and wild boar (Giammaroli 
et al., 2011). In a recent study 44 sardinian isolates collected during 1978-2014 were 
further characterised, through the analysis of p30, CD2V and I73R/I329L variable 
regions (Sanna et al., 2016). Researchers showed that Sardinian isolates can be 
divided into two sub-groups also by the sequences comparison of the CD2v gene: 
oldest Sardinian isolates (1978-1990) displayed 8 PPPKPC identical hexamers 
interrupted in the midst by a SPPKPC and a RPPKCP motifs and followed by an 
hexamer with an aminoacidic substitution (PPSKPC rather than PPPKPC), in 
contrast viruses isolated in recent years (from 1990 to 2014) show 7  identical repeats 
with the same central interruption where the last hexamer was not modified (Sanna et 
al., 2016). These studies suggest that since 1990 the ASF outbreaks in Sardinia are 
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1.4 Control of ASF in Sardinia 
As above stated, in Sardinia the disease first occurred in 1978 and now is endemic. 
The disease originated in the south part of Sardinia and it was probably introduced 
from Spain through food products containing uncooked pork, which were used to 
feed sardinian pigs (Mannelli et al., 1997). As previously stated, Ornithodoros ticks 
are not involved in the epizootic cycle of ASF in Sardinia and the control of other 
risk factors present in the island is necessary for effectively eradicate the disease 
(Mur et al., 2016b). The persistence of ASFV is probably due to extensive pig 
farming that has been practised for centuries and of the presence of endemically 
infected wild boar (Firinu et al., 1988, Costard et al., 2009). In a recent study a 
Bayesian multivariable logistic regression mixed model was used to assessed the 
factors associated to the ASFV occurrence in Sardinia. Researchers found that ASFV 
persistence was associated to particular socio-cultural, productive and economical 
factors found in the region, particularly to large number of confined farms (most of 
them backyard), high road density, high mean altitude, large number of open 
fattening farms, and large number of pigs per commune (Martinez-Lopez et al., 
2015).  
In the last decades several legislative measures were developed in order to eradicate 
this disease.  
The 14th February 1968 ministerial decree (‘ordinanza ministeriale’) disposed that 
the mayor, after notification of ASF presence or suspect, ordered sequestration 
(‘sequestro di rigore’) of infected, suspected infected and suspected contaminated 
animals. The ‘provincial veterinarian’ (‘veterinario provinciale’), after mayor’s 
provisions, issued with urgency decrees of ‘infectious zone’ (‘zona infetta’) and 
‘protection zone’ (‘zona di protezione’) and ordered immediate killing of infected, 
suspected infected and suspected contaminated animals. The decrees of ‘infectious 
zone’ (‘zona infetta’) and ‘protection zone’ (‘zona di protezione’) were revoked 
respectively at least 60 and 30 days after the last outbreak (OM 14-2-1968). 
In the following years several modification were made to this legislative measure, to 
more efficiently fight against ASF. The Member States of the European Union 
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moved from a diversity of national control policies towards a common, community 
wide approach based on notification of outbreaks, harmonized control measures, 
uniform diagnostic procedures and contingency plans. In 2002 an EU directive was 
issued to determine actions to be taken within the EU to fight against ASF, including 
measures to be applied in case of an outbreak or a suspect or presence of ASF in wild 
boar (direttiva 2002/60/CE). In 2005 an EU decision was issued focussing on the 
presence of ASF in Sardinia. This decision established rules about movements, 
shipments, stampings (‘bollatura’) of sardinian pigs and pig products, to avoid 
dissemination of the disease in other areas of the EU (decisione 2005/363/CE). 
Moreover, the decision 2005/362/CE was issued with the aim to eradicate ASF from 
wild boar in Sardinia (decisione 2005/362/CE). The decision 2005/363/CE has been 
recently abrogated and it is currently in force the decision of the European 
Commission of the 27th of March 2014, which will be effective till the 31st of 
December 2017. According to this decision, there is a prohibition to export live pigs, 
porcine sperm, ovules and embryos, pork and any product containing pig meat from 
Sardinia (and other areas within the EU where ASF cases has been recently 
reported). There are dispensations to export pork and products containing pig meat 
from Sardinia if they are made from pigs born and bred outside Sardinia and other 
areas with ASF. Moreover there are dispensation to export products containing pig 
meat if they are processed with a treatment that guarantee that there will be no risk 
related to ASF (decisione di esecuzione 2014/178/UE). 
According to the extraordinary ASF eradication plan, since 2014 Sardinian local 
authorities adopted further measures to eradicate ASFV from Sardinia (Deliberazione 
50/17 del 16.12.2014 Regione Autonoma della Sardegna, Legge Regionale n.34 del 
22.12.2014, Determinazione 87 del 11.2.2015 Regione Autonoma della Sardegna). 
According to the current legislation, in case of an ASF outbreak the official 
veterinarian must contact the ‘Unità di Crisi Locale’, a group of experts which 
coordinate the execution of  the legislative measures.  
Further measures were adopted to contrast the contact between domestic pigs and 
wild boars. In fact in Sardinia wild boar are likely to play an important role in 
facilitating virus persistence in areas where they lives in continuous contact with free 
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ranging domestic pigs (Costard et al., 2009). Every pig farm should adopt measure to 
avoid pigs-wild animals contacts and every pig should be kept on holdings, under 
human control. If feral pigs are detected, they are going to be killed by official 
veterinarians, even if they don’t display ASF clinical signs (Legge Regionale n.34 
del 22.12.2014, Determinazione 87 del 11.2.2015 Regione Autonoma della 
Sardegna). 
Every pig owner should register animals at the ‘Banca dati nazionale’ and every farm 
is subjected to official controls. Pigs are examined by official veterinarians, who also 
assess if in the farm there are effective measures to avoid contact between domestic 
and feral pigs/wild boars. Official veterinarians collect pig blood, which is sent to the 
Istituto Zooprofilattico Sperimentale (IZS) of Sardinia, where serological assays to 
detect antibodies against ASFV are performed. A farm became ‘Azienda certificata 
per PSA’ if it was inspected at least once in the previous 12 months by an official 
veterinarian, every pig did not display ASF clinical signs and did not present 
antibody against ASFV (Legge Regionale n.34 del 22.12.2014, Determinazione 87 
del 11.2.2015 Regione Autonoma della Sardegna).  
Further measures were taken also to control the spread of the disease in the wild boar 
population. Hunters must not leave organs or pieces of the carcass in the field, must 
collect wild boar blood sample for analysis, must inform an official veterinarian in 
case of finding of dead wild boar Legge Regionale n.34 del 22.12.2014, 
(Deliberazione 50/17 del 16.12.2014 Regione Autonoma della Sardegna). In some 
area (‘macroareali’), displayed in Figure 1.9, hunt is forbidden unless special 
requirements are fulfilled (Determinazione n. 7 del 15.10.2015, Regione Autonoma 
della Sardegna, Determinazione n. 25 del 20.11.2015, Regione Autonoma della 
Sardegna).   
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
 
Figura 1.9. Area (‘macroareali infetti nel selvatico’) of Sardinia where wild boar 
hunt is forbidden (Determinazione n. 25 del 20.11.2015, Regione Autonoma della 
Sardegna). 
 
1.5 ASF diagnosis in Sardinia 
Samples of domestic pigs and wild boars, collected by official ASL veterinarians, are 
sent to the IZS of Sardinia. That institute is responsible for the ASF diagnosis in 
Sardinia (Legge Regionale n.34 del 22.12.2014, Determinazione 87 del 11.2.2015 
Regione Autonoma della Sardegna). 
According to the current legislation, ASF should be suspected every time that 
animals display: fever (more than 40°C), lack of appetite, cutaneous and 
subcutaneous haemorrhaging, abortion, death of pigs of any ages without 
identification of other causes. ASF should be suspected every time there is death, 
infertility or abortion without an identified cause. Samples should be collected in 
case of outbreaks, epidemiological link with an outbreak, serological positivity, death 
animal or abortion. Sample suitable for virus isolation are: heparin blood, spleen, 
kidney, lymph nodes, tonsils, long bone (for bone marrow collection) and foetus 
(Decisione della Commissione del 26 maggio 2003 recante approvazione di un 
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manuale di diagnostica della peste suina, OIE Manual of Diagnostic Tests for 
Aquatic Animals, 2012).  
Techniques used to identify ASFV are: 
• Direct immunofluorescence, to detect the virus in tissue samples; 
• Haemoadsorbing test (Malmquist test); 
• PCR and RT-PCR, to detect ASFV in any kind of sample, as heparin blood, 
bone marrow, serum, tissue and organs not well conserved; 
• Sequencing and molecular epidemiological analysis, to analyse all the 
isolates positive at the Malmquist test. 
In case of a positive result in one of the previous assays, an ASFV outbreak is 
opened. Positive samples should be re-tested with a different assay, even on a 
different animal in the same farm. In case of an ambiguous result or in case of a 
positive result in the absence of clinical symptoms or pathological lesions of ASF, a 
test to isolate the virus should be performed. On these samples, one of the following 
test is performed: PCR, Real Time PCR, Malmquist Test. 
Serological assays to detect antibodies against ASFV are performed on blood 
samples. The first serological assay to be used is the ELISA and in case of a positive 
result an immunoblotting assay is also performed. Results of the serological assay 
should be evaluated considering the clinical symptoms and the epidemiological 
situation, in case of a suspected or an opened ASF outbreak (Decisione della 
Commissione del 26 maggio 2003 recante approvazione di un manuale di diagnostica 
della peste suina, OIE Manual of Diagnostic Tests for Aquatic Animals, 2012).  
During the hunting season, according to the extraordinary ASF eradication plan 
(Deliberazione 50/17 del 16.12.2014 Regione Autonoma della Sardegna) official 
veterinarian collect blood samples from dead wild boar, which are sent to the IZS of 
Sardinia to detect antibodies against ASFV, by ELISA and immunoblotting. In the 
area displayed in Figure 1.9, also spleens are collected by official veterinarians and 
are sent to the IZS of Sardinia to detect ASFV, by direct immunofluorescence, 
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1.6 ASF vaccines and antiviral agents 
Currently there are no vaccine against ASFV. Pigs that survive inoculation with 
ASFV isolates with reduced virulence can be protected from challenge with the 
homologous or closely related virulent viruses (Leitão et al., 2001, Oura et al., 2005, 
King et al., 2011), indicating that anti-ASFV immune response(s), including 
protective immune response(s), developed in these pigs prior to challenge with the 
virulent virus (Takamatsu et al., 2013).  
Efforts has been done to develop attenuated ASFV strains, by deletion of specific 
genes from virulent ASFV isolates. Independent deletions of the UK (DP69R) or NL 
(DP71L) genes from the ASFV E75 (Zsak et al., 1998, Zsak et al., 1996) and 
deletion of the 9GL (B119) gene from the virulent Malawi Lil-20/1 strains (Lewis et 
al., 2000) resulted in creation of recombinant deletion viruses with reduced virulence 
in swine, able to confer protection to challenge with the homologous parental virus 
(Zsak et al., 1998, Zsak et al., 1996, Lewis et al., 2000). Multigene family (MGF) 
360 and 530/550 have been implicated in the modulation of type I interferon (IFN) 
response, so additional copies of these genes were deleted or interrupted from a 
virulent genotype I isolate, Benin 97/1. The deleted mutant (BeninMGF) was 
attenuated in pigs and immunisation and boost with this virus protected against 
challenge with a lethal dose of Benin 97/1, suggesting that deletion of IFN 
modulators is a promising route for rational attenuation of virulent ASFV isolates to 
construct candidate vaccine strains (Reis et al., 2016). Recent studies focused on the 
creation of a deletion vaccine strain based on the attenuation of the virulent and 
epidemiologically relevant Georgia2007 isolate. Deletion of 9GL (B119L) resulted 
in a mutant (ASFV-G-9GL) virus with limited replication in swine macrophages, 
but able to confer protection to homologous challenge when administered at a lower 
dose (102-103 HAD50) 21-28 days before infection with the parental strain (O’Donnel 
et al., 2015). Depletion of six genes belonging to MGF 360 and 505 lead to the 
creation of a vaccine strain (ASFV-G-MGF) able to replicate efficiently in primary 
macrophage cell cultures, completely attenuated in swine, and vaccination with 102-
104 HAD50 protected pigs to challenge with the virulent parental strain (O’Donnel et 
al., 2015). Despite both vaccine strains (ASFV-G-Δ9GL and ASFV-G-ΔMGF) were 
efficient in inducing protection, they presented concerns regarding their safety. So a 
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new mutant, ASFV-G-Δ9GL/ΔMGF, harboring deletions of both 9GL and 
MGF360/505 genes, was constructed. This virus was highly attenuated in swine, but 
did not induce protection against challenge with the virulent parental ASFV-G isolate 
(O’Donnel et al., 2016). In addition, deletion of the thymidine kinase gene was 
performed in a strain of Georgia adapted to replicate in Vero cells (ASFV-G/V). This 
mutant (ASFV-G/V-ΔTK) was completely safe in pigs, but unable to provide 
protection to challenge with the virulent parental strain (Sanford et al., 2016). These 
results suggest caution towards approaches involving genomic manipulations when 
developing rationally designed ASFV vaccine strains isolate. In addition, even if 
attenuated viruses could be used to protect pigs against challenge with virulent 
strains, the use of this kind of vaccines has some risks, due to the fact that the 
attenuated virus could revert to virulence in vivo.  
The use of vaccine strains which undergo a single cycle of infection but do not 
produce infectious progeny would avoid this risk. However higher virus load would 
most likely be required to induce protection (Dixon et al., 2013). In the past it has 
been shown that inactivated vaccines are not useful to protect pigs against ASFV 
(Stone et al., 1967; Mebus, 1988) and recently it has been reported that modern 
adiuvants, like PolygenTM or Emulsigen®-D, do not increase the efficacy of these 
kind of vaccines (Blome et al., 2014). The construction of vaccines using techniques 
of molecular biology, not including the whole virus but immunological 
proteins/peptides, would be useful for the eradication of the disease. Nevertheless, 
knowledge of protective antigens is essential to create these kind of vaccines (Dixon 
et al., 2013). 
Antibody response against ASFV can be detected even 7 days pi (Parker and 
Plowright, 1968), but there are controversies about the ability of these antibodies to 
neutralise the virus (Escribano et al., 2013). Nevertheless, it is not possible to 
exclude that antibody response does not contribute to protection. Some studies 
showed that administration of sera of immune animals to infected pigs delay clinical 
symptoms, reduce viremia and increase the survival probability (Onisk et al., 1994). 
Instead, several studies reported the importance of the cellular immune response 
against ASF, especially of the CD8+ T cells (Argilaguet et al., 2012, Argilaguet et 
al., 2013, Oura et al., 2005). 
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Recombinant viruses represent an attempt to design a safe and efficient ASFV 
vaccine. A recombinant Newcastle disease virus (rNDV) expressing the ASFV 
protein 72 (p72) was recently constructed. The recombinant virus was safe in mice 
and animals immunized with rNDV/p72 developed high titers of ASFV p72 specific 
IgG antibody and T cell response (Chen et al., 2016). Futher studies in pigs will 
evaluate the efficacy of this potential vaccine candidate for preventing ASF. 
Lokhandwala et al. (2016) recently tested the safety and immunogenicity of an 
adenovirus-vectored ASFV multi-antigen cocktail. Codon-optimized synthetic genes 
encoding p32, p54, pp62, and p72 ASFV antigens were used to generate a 
recombinant adenovirus. Immunization with the cocktail rapidly induced ASFV 
antigen-specific antibody and cellular immune responses against all the antigens. 
Importantly, significant antigen-specific IFN-γ responses were detected post-priming 
and post-boosting (Lokhandwala et al., 2016). A challenge study need to be 
performed in order to evaluate the relevance of the induced immune responses in 
regards to protection. 
DNA vaccines, where one or more genes encoding immunological proteins are 
inserted, can be used to induce a stronger cellular response. To date several ASFV 
proteins have been identified as target of the immunological response, such as p30 
and p73 (Leitao et al., 1998, Alonso et al., 1997). Moreover hemagglutinin (HA) 
showed the ability to confer protetion in the absence of neutralising antibodies (Ruiz-
Gonzalvo et al., 1996). Recent studies showed that ASFV vaccines based on the 
proteins p30, p54 and HA were able to induce a T cell response and partially 
protected pigs against challenge with a virulent ASFV isolate (Argilaguet et al., 
2012, Argilaguet et al., 2013). In fact a DNA vaccine containing p30, p54 and HA 
fused to ubiquitin was able to protect more than 50% of the vaccinated pigs against 
challenge with a virulent ASFV strain, in the absence of antibody response 
(Argilaguet et al., 2012). Protected pigs showed a peak in the number of CD8 T cells 
3 days post vaccination and leukopenia was delayed and had lower intensity. In the 
same study two 9mers target of the T cell response were identified, both located on 
HA, and immunodominance hierarchy in the T cell response and SLA I restriction 
were observed (Argilaguet et al., 2012). In addition, in another study the ASFV 
proteins p54, p30 and HA were inserted in a baculovirus vector (BacMam-sHAPQ), 
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under control of the human cytomegalovirus promoter (CMVie). The use of this 
vaccine induced a strong T cell response, positively correlated with protection in 
survived pigs (4 out of 6), in the absence of antibody response (Argilaguet et al., 
2013). The use of peptide vaccine against ASFV has also been tested. A vaccine 
based on 17 ASFV immunological peptides failed to protect pigs against an ASFV 
lethal challenge, nevertheless it was able to statistically significantly delay mortality 
(Ivanov et al., 2011).  
Recently, it has been reported that other two ASFV proteins, CD2v (EP402R) and C-
type lectin (EP153R), represent significant protective antigens for ASFV, so they 
should be targeted in future vaccine design and development (Burmakina et al., 
2016). 
Further studies should be performed on the interaction of ASFV with the porcine 
immune system, to understand how attenuated virus induce protection and to identify 
targets of the protective immune response, generating information useful to underpin 
vaccine development efforts. 
 
Several studies focused on the development of antiviral agents against ASFV. Those 
treatments might be beneficial in areas located close to the affected farms, in order to 
isolate the epidemic area (Zakaryan and Revilla, 2016). Potential anti-ASFV 
compounds can be divided into two groups: 1) agents that affect ASFV replication 
cycle (from virus attachment to release of virus progeny); 2) agents that target host 
cell factors involved in virus replication. Antiviral agents belonging to the first group 
are: sulphated polysaccharides which affect ASFV attachment; cholesterol removing 
agents that inhibit viral entry; drugs blocking endosomal acidification (ammonium 
chloride, amantadine, chloroquine, and methylamine) required for ASFV replication 
(Zakaryan and Revilla, 2016). Agents belonging to the second group are: 
fluoroquinolones, a family of drugs which interfere ASFV replication targeting the 
type II topoisomerase (Mottola et al., 2013); lauryl-galattate, which inhibits both 
cellular and viral DNA synthesis (Hurtado et al., 2008); polyphenolic phytoalexins, 
which interfere with viral DNA replication, late viral protein synthesis and viral 
factory formation (Galindo et al., 2011). A recent study tested the antiviral effect of 
five flavonoids on the replication of ASFV in Vero cells. Researchers observed a 
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dose-dependent anti-ASFV effect of apigenin in vitro. Apigenin was highly effective 
at the early stages of infection; it inhibited ASFV-specific protein synthesis and viral 
factory formation (Astghik et al., 2016). Neverthelss the antiviral activities of the 
compounds mentioned were only tested in vitro and evidence of their in vivo efficacy 
is still lacking (Zakaryan and Revilla, 2016).  
 
1.7 Immunology against ASFV         
As above stated, pigs that survive inoculation with ASFV isolates with reduced 
virulence can be protected from challenge with the same or closely related virulent 
viruses (Leitão et al., 2001, Oura et al., 2005, King et al., 2011). This indicates that 
anti-ASFV immune response(s), including protective immune response(s), developed 
in these pigs prior to challenge with the virulent virus (Takamatsu et al., 2013). The 
analysis of the immune mechanisms underlying the development of this immunity 
will generate information useful for the development of un efficient vaccine against 
this disease. 
 
1.7.1 ASFV and innate immunity 
ASFV mainly targets myeloid lineage cells, especially monocytes and macrophages, 
which are thought to be crucial for viral persistence and dissemination (Sierra et al., 
1991, Sánchez-Cordón et al., 2008). ASFV encode different genes to avoid apoptosis 
(such as A224L, A179L, EP153R), so infected macrophage can survive and 
disseminate the virus into the whole organism (Nogal et al., 2001, Galindo et al., 
2008, Hurtado et al., 2004, 2011). 
Infected monocytes-macrophages containing virus replication sites may synthesize 
and release monokines (TNF-, IL-1) which would trigger lymphocytes apoptosis 
(Fernandez de Marco et al., 2007). In fact it has been speculated that the level of 
apoptosis depends on the amount of cytokines released, and this in turn depends on 
the number of ASFV infected macrophages, and this may explain the greater 
presence of lymphocyte apoptosis of highly virulent isolates such as Malawi 
compared with the less virulent isolates such as Malta (Oura et al., 1998). 
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To date several studies analysed the cytokine response of monocyte/macrophages to 
ASFV (Gomez del Moral, 1999, Gil et al., 2003, Gil et al., 2008, Zhang et al, 2006) 
and more recent study reported the expression of chemokines after ASFV infection 
(Fishbourne et al., 2013). It has been shown that the low-virulent ASFV/NH/P68 
induces enhanced expression and production of relevant regulatory cytokines 
(IFN, TNF- and IL12) in comparison to the highly virulent ASFV/L60 (Gil et 
al., 2008) and it has been reported that the low virulence strain OURT88/3 induces 
higher expression of key inflammatory chemokines (CCL4, CXCL8, CXCL10) 
compared to infection with high virulence strain Benin 97/1 (Fishbourne et al., 
2013). A different response of antigen presenting cells (APCs) to ASFV isolates of 
reduced virulence could lead to the acquisition of a protective immunity rather than 
disease.   
A recent study assessed the effect of ASFV on the expression of surface markers on 
bone marrow-derived macrophages, obtained from femur bones. Flow cytometry was 
used to analyse the expression of several surface markers in ASFV infected cells: 
MHC II, CD163, CD203a, CD45, CD16 (Lithgow et al, 2014). They observed that 
MHC II, CD203a, CD45 are not up-regulated after ASFV infection and CD16 is 
instead down-regulated in macrophages after ASFV infection. This study produced 
results contrasting to a previous work, where the importance of CD163 in ASFV 
infection was described (Sanchez-Torres et al., 2003). In fact Lithgow et al. (2014) 
observed that this marker is not up-regulated after ASFV infection and the virus is 
able to infect both CD163+ and CD163- bone marrow-derived macrophages (Lithgow 
et al., 2014). The effect of the virus on the expression of this marker on 
monocytes/macrophages should be better defined.  
DC are one of the target of ASFV. DC are thought to be the most potent antigen 
presenting cells (APCs) that play an important role in induction of adaptive immune 
responses, by processing antigens, expressing lymphocyte co-stimulatory molecules, 
migrating to lymphoid organs and secreting cytokines (Banchereau and Steinman., 
1988). These cells express a variety of specialised pattern recognition receptors 
(PRRS), including Toll-like receptors (TLRs) for the recognition of pathogen 
associated molecule patterns (PAMPs) (Gijzen et al., 2006). DC can broadly be 
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divided into two subpopulations: conventional or myeloid DC (mDC), with main 
function in antigen presentation, and plasmacytoid DC (pDC), specialized in rapidly 
secreting large amounts of type I interferon (McCullough and Summerfield, 2009).  
Despite the important role that DC play in innate and adaptive immunity against 
pathogens (Banchereau and Steinman., 1988), little is known about their interaction 
with ASFV. ASFV is able to infect skin-derived DC and this interferes with a 
subsequent infection with FMDV, in fact ASFV inoculation 3 hours before FMDV 
inoculation blocked FMDV infection (Gregg et al., 1995a). In vivo it has been 
observed that ASFV is able to infect interdigitating DC (iDC) and in pigs infected 
with a virulent ASFV isolate there is reduction in the number of iDC in mandibular 
lymph nodes from 3 days pi (Gregg et al., 1995b). A recent study reported that 
infection in vitro of porcine leucocytes enriched for DC with ASFV induced high 
levels of type I interferon, suggesting that ASFV-infected pDC could be a potential 
source of interferon in animals undergoing acute ASF (Golding et al., 2016). 
In the same study it was reported an important role of type I IFN in preventing 
replication of attenuated ASFV strains in macrophages. Researchers observed that 
replication of attenuated strains, containing MGF 360/530 deletions, but not virulent 
ASFV isolates in porcine alveolar macrophages was inhibited by recombinant 
porcine IFN-α (Goldwing et al., 2016). Also a former study described that IFN- has 
an important role in protection against ASFV: it can reduce ASFV replication in both 
porcine monocytes and alveolar macrophages, inhibiting synthesis of late ASFV 
proteins (Esparza et al., 1988). Virulent isolates have developed mechanism to 
overcome IFN antiviral activity, in fact MFG 360/530 genes either directly or 
indirectly suppress a type I IFN response (Afonso et al., 2004). Deletion of MGF 
360/530 probably results in absence of interference with antiviral genes induced by  
IFN-. Type I interferon can induce interferon-induced transmembrane (IFITM) 
protein expression, a group of antiviral restriction factors that restrict viral 
progression at entry. A recent study reported that infection with cell-adapted ASFV 
isolate BA71V, which is IFN sensitive, was able to induce IFITMs expression. High 
levels of this proteins caused a collapse of the endosomal pathway to the perinuclear 
area. Expression of IFITM1, 2 and 3 reduced virus infectivity in Vero cells, with 
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IFITM2 and IFITM3 having an impact on viral entry/uncoating (Munoz-Moreno et 
al., 2016). 
Little is known about the effect of ASFV on natural killer (NK) and -T cells, which 
are two major lymphocyte populations of the innate immune system. Their 
activation/inhibition could be crucial, given that swine possess only a small number 
of cytotoxic T-cells, but large numbers of lymphocytes with innate cytotoxic activity, 
especially γδ-T cells (Denyer et al., 2006). In young pigs, γδ-T cells and NK cells 
represent 50% and 10% of the total peripheral blood lymphocyte population, 
respectively, although their frequencies decrease with age (Denyer et al., 2006, 
Gerner et al., 2009). It is well known that NK cells possess the ability to attack 
pathogen-infected and malignant cells and to produce immunostimulatory cytokines, 
such as IFN-γ and TNF-α (Gerner et al., 2009). Specifically, these cells are triggered 
to kill or ignore cells (cancer cells and virus-infected cells) depending on a balance 
of inhibitory and activating signals received through ligands on potential targets. 
Activation of these cells by most pathogens is led by accessory cells, especially 
mature DC, which release cytokines and provide contact-dependent signals to NK 
cells (Newman et al., 2007, Trinchieri, 2003, Fehniger and Caligiuri, 2001). Several 
studies suggest the importance of NK cells in response to ASFV (Leitao et al., 2001, 
Norley et al., 1983, Martins et al., 1994). Leitao et al. (2001) showed that NK 
activity was correlated to survival after ASFV infection. In that study 31 pigs were 
inoculated with ASFV/NH/P68 and some pigs developed ASF chronic type lesions 
and others instead remained asymptomatic. In animals developing lesions and 
viraemia, NK activity levels were close to that of control animals, instead pigs 
remaining asymptomatic after infection had elevated NK cell activity (Leitao et al., 
2001). Instead another study reported that pigs infected with ASFV exhibited a 
suppressed NK activity, but that was probably due to the sensitivity of NK cells to 
increased temperatures. In fact NK cell activity was lost when cells were incubated at 
40°C in vitro and the authors suggested that pyrexia might be the cause of the 
depressed NK cell activity (Norley et al., 1983). Martins et al. (1994) showed that 
NK cell activity of PBMC derived from naïve pigs was stimulated in vitro by non-
virulent NH/P68 virus, but depressed by virulent Lisbon 60 isolate. 
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-T cells represent another significant lymphocyte population originally 
defined as effector lymphocytes of the innate immune system but now being 
regarded, like NK-cells, as also playing an important role in the activation and 
regulation of immune responses. -T cells express a subtype of T cell receptor 
(TcR) different from the conventional  TcR and display characteristics of both T 
cells and cells of the innate immune system. They recognize conserved non-peptide 
antigens that are up-regulated by stressed cells, by both TcR and non-TcR molecules, 
such as TLRs and NK receptors (NKRs). Like NK cells, the balance between 
activating and inhibitory signals regulates the  cell response (Bonneville et al., 
2010). cells can produce cytokines, such as IFN- and TNF-, involved in the 
protection against viruses and other intracellular pathogens, or cytokines that 
contribute to the protection against extracellular parasites (IL-4, IL-5 and IL-13), 
extracellular bacteria (IL-17) and also immunosuppressive cytokines (Transforming 
Growth Factor (TGF)- and IL-10) (Bonneville et al., 2010). Activation of cell 
responses may therefore be direct or indirect, mediated by the interaction with APCs, 
such as DC, through release of pro-inflammatory cytokines and expression of ligands 
for TcR and NKRs (Devilder et al., 2009). In swine, -T cells act both as 
cytotoxic cells and professional antigen presenting cells (APCs). They can express 
CD8 and MHC II molecules, and the latter seems to be correlated with T cell 
activation in swine (Gerner et al., 2009).  
Little is known about the interaction of ASFV with -T cells. In a study 
researchers used lymphocytes from ASFV immune pigs and observed that these cells 
are able to present viral antigen (Takamatsu et al., 2006), however the interaction of 
ASFV with -T cells should be better studied in the future. 
 
1.7.2 ASFV and adaptive immunity 
1.7.2a Humoral Immunity 
Almost all virus can be neutralised by antibodies. However, there is some 
controversy about antibody-mediated neutralization of ASFV with sera from 
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convalescent pigs and about the protective relevance of antibodies in experimentally 
vaccinated pigs (Escribano et al., 2013). 
In the past some it was indicated the lack of neutralizing activity of sera from 
animals infected with ASFV (Hess, 1981), nevertheless evidence of neutralising 
antibodies against this virus has been provided by numerous groups in the last 15 
years (Escribano et al., 2013). 
Onisk et al. (1994) examined the role of anti-viral antibodies in homologous 
protective immunity to a virulent ASFV strain E75 by passive transfer experiments 
in swine. 85% of animals that received anti-ASFV immunoglobulin survived 
challenge infection and remained clinically normal following challenge, while 100% 
mortality was observed in control group animals. These data indicate that anti-ASFV 
antibodies alone protect swine from lethal infection with virulent ASFV (Onisk et 
al., 1994). Also Zsak et al. (1993) showed that sera from convalescent swine infected 
with an attenuated AFV isolate (E75CV1-4, derived from the Spanish strain E75 and 
adapted to grow on CV1 cells and propagated in pig macrophages) neutralized the 
infectivity of virulent ASFV isolates E75, E70, Lisbon 60, Malawi Lil 20/1 and a low 
passage tissue culture adapted variant of E75 (E75CV/V3) by 86-97% in Vero and 
macrophage cell cultures. Unexpectedly, these immune sera failed to neutralize high 
passage tissue culture adapted ASFV variants including Lisbon 60, Haiti, Dominican 
Republic I, Dominican Republic II, and Brazil II. These results suggest that tissue 
culture adaptation of ASFV isolates may be associated with loss of specific 
determinants associated with virus neutralization (Zsak et al., 1993). 
In fact few years later, Gomez-Puertas et al. (1997) showed that highly passaged 
ASF viruses were resistant to neutralization by antisera from convalescent pigs or 
antibodies generated against individual viral proteins which neutralized low-passage 
viruses. They showed that the absence of neutralization of high-passage viruses is not 
due to antigenic variability of critical epitopes, but is linked to the relative amount of 
phosphatidylinositol in viral membranes, which is higher in low-passage viruses. The 
data suggest that phosphatidylinositol is essential for a correct epitope presentation to 
neutralizing antibodies. Additionally, the removal of phosphatidylinositol from a 
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low-passage virus by a specific lipase transformed this virus from neutralizable to 
non neutralizable (Gomez-Puertas et al., 1997). 
Anti-ASFV antibodies neutralize the virus before and after binding to susceptible 
cells. Gomez-Puertas et al. (1996) observed that neutralising antibodies inhibited 
about 80% of virus attachment and more than 90% of virus internalization and the 
combination of both mechanisms neutralized more than 95% of virus infectivity. In 
addition, researchers reported that antibodies to proteins p72 and p54 are involved in 
the inhibition of a first step of the replication cycle related to virus attachment, while 
antibodies to protein p30 are implicated in the inhibition of virus internalization 
(Gomez-Puertas et al., 1996). Moreover, proteins p54 and p30 mediate specific 
interactions between ASF virus and cellular receptors and that simultaneous 
interference with these two interactions has a complementary effect in antibody-
mediated protection (Gomez-Puertas et al., 1998). 
Even if the existence of neutralising anti-ASFV antibodies has been demonstrated, a 
persistent non-neutralized ASFV fraction of about 10% is found with most 
convalescent swine sera in vitro neutralization assay. Probably, the main cause for 
the persistent surviving virus fraction observed in neutralization assay if the 
induction of blocking antibodies, and this could also explain the persistent infections 
observed in some convalescent pigs (Gomez-Puertas and Escribano, 1997). 
Although antibody-mediated immune mechanisms have been shown to be important 
in immunity to ASF, a study showed that neutralizing antibodies to some ASFV 
proteins (p30, p54, and p72) are not sufficient for antibody-mediated protection. In 
that study pigs immunized with baculovirus-expressed p30, p54, p72 from the 
pathogenic ASFV isolate Pr4 died 7-10 days post challenge with 104 TCID50 of Pr4 
virus. Nevertheless, test group animals exhibited a 2-day delay to onset of clinical 
disease and reduced viremia levels at 2 days post infection in comparison to the 
control group (Neilan et al., 2004). Further studies are needed to clarify the role of 
ASFV antibodies in protection. 
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1.7.2b Cellular Immunity 
Despite the controversy on the role of neutralising antibodies in protection against 
ASFV, several studies demonstrated the importance of cellular immune response 
against this virus.  
IFN- has an important role in protection against ASFV, in fact it reduces ASFV 
replication in both porcine monocytes and alveolar macrophages. Instead, TNF- 
does not show antiviral activity in either type of cells (Esparza et al., 1988). 
Several study analysed the role of T cells in response to this virus. The first 
demonstration of ASFV specific lymphocyte proliferation was described by Wardley 
and Wilkinson (1980) 10 days pi with a non-virulent virus, however they did not 
detect ASFV specific lymphocyte proliferation after infection with a virulent virus, 
presumably because the pigs died too quickly. One year later Sanchez-Vizcaino et al. 
(1981) showed that infection with moderate or non-virulent strains of ASFV induced 
ASFV specific memory T cell proliferation against homologous virus. Also Revilla 
et al. (1992) observed that a non-virulent ASFV isolate (BA71V) induced memory T 
cell response against homologous virus. In fact PBMC from inbred pigs that were 
immunized with autologous macrophages infected with BA71V produced IFN- 
when challenged in vitro with homologous or attenuated isolates of the ASF virus, 
but not with heterologous or virulent isolates (Revilla et al., 1992). 
Later experiments (Martins et al., 1993, Scholl et al., 1989) examined ASFV specific 
T cells activities in swine that had recovered from the non-haemabsorbing ASFV 
isolate NH/P68. Scholl et al. (1989) showed that blood mononuclear cells (BMC) 
from swine surviving experimental infection with NHV exhibited a strong virus-
induced, antigen-specific blastogenic response, absent in control pigs. This ASFV-
induced blastogenesis was dependent on virus dose and on the presence of adherent 
cells (Scholl et al., 1989). Few years later Martins et al. (1993) show that ASFV 
specific CTL activity was triggered in swine infected with the NHV isolate. PBMC 
from such infected swine showed significant activity in CTL assays, using cultured 
ASFV-infected porcine blood derived macrophages as target cells. This CTL activity 
appeared to be SLA class I restricted because it was higher in the infected 
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macrophages of the same haplotype, and was blocked by anti-CD8 monoclonal 
antibodies (mAbs) but not by anti-CD4 mAbs. Experiments with macrophages 
infected with different ASFV isolates revealed that there was marked lysis of 
macrophages infected with the virulent L60 isolate but less lysis of macrophages 
infected with the DR-II and Tengani isolates (Martins et al., 1993). King et al. 
(2011) observed that the ability of lymphocytes from immune pigs to release IFN- 
in vitro in response to different isolates was correlated with protection against ASF.  
Immunisation of pigs with the non-virulent OURT88/3 isolate followed by the 
closely related virulent OURT88/1 isolate could confer protection against challenge 
with virulent isolates from Africa, including the genotype I Benin 97/1 isolate and 
genotype X Uganda 1965 isolate. Cross-protection was correlated with the ability of 
different ASFV isolates to stimulate production of IFNby lymphocytes from 
OURT88/3 and OURT88/1 immunised pigs, assessed in vitro by ELISPOT (King et 
al., 2011). 
Few recent studies underlined the importance of T cell response in ASFV-vaccine 
induced protection. As above stated, ASFV vaccines based on the proteins p30, p54 
and HA were able to induce a T cell response and partially protected pigs against 
challenge with a virulent ASFV isolate (Argilaguet et al., 2012, Argilaguet et al., 
2013). A DNA vaccine containing p30, p54 and HA fused to ubiquitin was able to 
protect more than 50% of the vaccinated pigs against challenge with a virulent ASFV 
strain, in the absence of antibody response (Argilaguet et al., 2012). In another study 
the ASFV proteins p54, p30 and HA were inserted in a baculovirus vector (BacMam-
sHAPQ), and the use of this vaccine induced a strong T cell response, positively 
correlated with protection in survived pigs (4 out of 6), in the absence of antibody 
response (Argilaguet et al., 2013). 
The critical importance of CD8+ lymphocytes on protective immunity to ASF was 
demonstrated directly by depleting CD8+ lymphocytes from ASF immune pigs in 
vivo. Researchers showed that depletion of CD8 T cells from pigs vaccinated with an 
avirulent ASFV isolate OURT88/3 resulted in a loss of protection when challenged 
(Oura et al., 2005). 
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A study on the phenotype of ASFV specific CD8+T cells revealed that there are two 
distinctive populations: a conventional (perforin+CD2+CD3+CD4-
CD5+CD6+CD8+CD16-) and a CD4+ phenotype ( 
perforin+CD2+CD3+CD4+CD5+CD6+CD8+CD16-),  both able to lyse ASFV infected 
syngeneic target cells (Denyer et al., 2006). In a recent study the phenotype of 
ASFV-specific double positive CTLs was characterised. Pigs were immunized by 
inoculating non-virulent ASFV isolate OURT88/3 and then challenged 4 weeks later 
with the related virulent isolate OURT88/1. Only one pig exhibited transient pyrexia 
and viraemia. Before challenge with OURT88/1, PBMC from immune pigs were 
stimulated in vitro for 5 days with OURT88/1 and the phenotypes of proliferated 
lymphocytes were analyzed. More than half (55.7%) of the proliferating CD4+ cells 
in the protected pigs expressed perforin, in contrast to only 13.8% of proliferating 
CD4+cells from the diseased pig (Takamatsu et al., 2013). Unpublished observations 
from Denyer, Stirling & Takamatsu revealed that IFN- positive lymphocyte 
population from ASFV stimulated immune PBMC was dominated by the CD4+CD8+ 
T cell phenotype, but only a third of these cells presented a typical memory helper T 
cell (CD4+CD8low) phenotype and the rest were CD8hiCTL (Takamatsu et al., 2013). 
Further investigation is needed to explore the contribution of CD4+CD8+ T cells in 
protection to ASF. 
Several studies were made in order to identify antigens recognized by ASF immune 
porcine T cells. In a study SLA inbred minipigs were experimentally infected with an 
attenuated isolate of the virus and CTL assays were performed using alveolar 
macrophages as target cells. It was observed that ASFV-specific cytotoxic T 
lymphocytes recognize and lysed p32, an immediate early ASFV protein (Alonso et 
al., 1997). Also the structural ASFV protein p72 was identified as target of CTLs. 
Researchers used expression vectors based on the Pseudomonas outer membrane 
lipoprotein I gene (oprI) to study ASFV-specific CTL activity. They observed that 
the aminoacid sequence HKPHQSKPILTDENDTQRTCSHTNP from the major 
structural ASFV protein (VP72) is presented by macrophages, which are lysed under 
restriction of SLA class I antigens (Leitão et al., 1998). Recently two 9-mer peptides 
within the ASFV haemagglutinin protein (CD2v, EP402R) were identified as CTL 
epitopes. Researchers tested a panel of 53 9mer peptides selected in silico from 
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within p54, p30 and sHA protein sequences. In silico prediction of CTL epitopes was 
based on their binding affinity to TAP, due to the fact that MHC I restricted epitopes 
can often be transported by TAP as N-terminal elongated peptide precursors. 
Immunodominance hierarchy in the responses and the SLA I restriction were also 
observed (Argilaguet et al., 2012). 
 
1.8 Aim, hypothesis and objectives 
There is a need to develop alternative strategies to improve the control of ASF 
outbreaks and minimize the need for mass culling. As previously stated, main target 
of the virus are cells of the myeloid lineage and this tropism is thought to be crucial 
for disease pathogenesis. A detailed characterization of the interaction of ASFV 
isolates of differing virulence with monocytes and macrophages subsets would aid 
the understanding of the immunological mechanisms underlying the disease, 
generating information to aid the development of marker vaccines. 
In this thesis, responses of monocytes and derived macrophage subsets to ASFV 
were investigated through the following two objectives: 
• To compare different methods to differentiate porcine monocytes into 
macrophages, assessing their phenotype, release of cytokines and 
susceptibility to ASFV infection (Chaper 3). 
• To determine the interaction of monocytes and macrophage subsets to 
the avirulent BA71V and the virulent 22653/14 ASFV strains, 
characterising their susceptibility to infection, expression of surface 
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CHAPTER 2.  MATERIALS AND METHODS 
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2.1 Animals and blood sampling 
Blood samples were obtained from 6 to 18 months old healthy crossbred pigs (Sus 
scrofa) housed at the experimental facility of the IZS of Sardinia (Sassari, Italy), 
authorized for animal research by Italian Ministry of Health. The ASFV negative 
status of the animals was confirmed by a commercial ELISA test (Ingenasa, Madrid, 
Spain) and by an immunoblotting test (OIE, 2012). Heparinized blood was collected 
by cranial vena cava puncture using a 50 mL syringe containing 5000 IU of sodium 
heparin (Thermo Fisher, Germany), connected to a mm 14-gauge needle (Delta Med, 
Mantova, Italy). Animal housing, handling and sampling procedures were performed 
in accordance with the local ethics committee, according to the guide of use of 
laboratory animals of the Italian Ministry of Health. 
 
2.2 Viruses 
The attenuated ASFV BA71V strain (kindly provided by EU Reference laboratory 
CISA-INIA, Madrid, Spain) is non pathogenic in swine and was obtained by 
adaptation to growth in Vero cells of the BA71 isolate (a highly virulent virus 
isolated in Badajoz, Spain in 1971) (Enjuanes et al., 1976). It belongs to the p72 
genotype I and cluster within sub-group V of the B602L gene (Bastos et al., 2003, 
Nix et al., 2006). BA71V was propagated in vitro by inoculation of sub-confluent 
monolayers of Vero cells, maintained in Dulbecco’s Modified Eagle Medium (D-
MEM) (Euroclone, Milan, Italy) supplemented with 50 g/ml gentamicin (Gibco, 
Thermo Fisher Scientific, Monza, Italy) and 10% foetal bovine serum (FBS) (Gibco, 
Thermo Fisher Scientific). Images of un-infected and infected Vero cells are 
displayed in Figure 2.1. After 1-2 days at 37°C, 5% CO2, a clear cythopatic effect 
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was observed and the supernatant was collected and pooled with a freeze-thawed cell 
lysate. The resultant pool was clarified by centrifugation at 3000g for 15 minutes in a 
rotating bucket centrifuge, aliquoted and stored at -80°C. Virus titres were obtained 
by serial dilution of the virus suspension on Vero cells followed by observation for 
cytopathic effect and crystal violet staining to identify infection rates as previously 
described (Carrascosa et al., 2011).     
 
         
Figure 2.1. Infection of Vero cells with BA71V. Vero cells were mock-infected (A) 
or infected for 24 hours with BA71V (B). In Figure B a clear cytophatic effect is 
visible. Images taken with an inverted microscope (Olympus, Tokjo, Japan), using a 
10X magnification. 
 
The highly virulent ASFV Sardinian field strain 22653/14 is placed in the p72 
genotype I and was isolated from the spleen of a naturally infected pig collected from 
a 2014 outbreak in the province of Cagliari (Exotic Disease Laboratory ASFV 
Archive, IZS of Sardinia, Sassari, Italy). Genotype of 22653/14 was determined by 
partial p72 gene characterization, as previously described (Bastos et al., 2003). 
ASFV 22653/14 was propagated in vitro by inoculation of sub-confluent monolayers 
of porcine monocytes/macrophages for no more than six passages (Malmquist and 
Hay, 1960). In brief, leukocytes were cultured in RPMI-1640 medium supplemented 
with 20% (v/v) autologous plasma, 100 U/ml penicillin and 100 µg/ml streptomycin. 
B A 
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After 2 days, non-adherent cells were removed and virus suspension was added to 
the adherent monocytes/macrophage monolayer. After 2 hours incubation, RPMI-
1640 medium supplemented with 1% (v/v) autologous plasma, 0.1% autologous 
erythrocytes, 100 U/ml penicillin and 100 µg/ml streptomycin was added. After 3 
days at 37°C in 5% CO2, the supernatant was collected and pooled with a freeze-
thawed cell lysate. The resultant pool was clarified by centrifugation at 3000g for 15 
minutes, aliquoted and stored at -80°C. Images of un-infected and infected 
macrophages are displayed in Figure 2.2. Viral titre of ASFV 22653/14 was obtained 
by serial dilution of the virus suspension on monocyte/macrophages in 96 well plates 
and cell cultures were observed for hemadsorption (Malmquist and Hay, 1960) or 
immunofluorescence (OIE, 2012). For detection of infected cells by 
immunofluorescence a FITC-conjugated polyclonal antibody against ASFV (kindly 
provided by the EU ASF Reference Laboratory CISA- INIA, Madrid, Spain) was 
used. In brief, medium was removed from each well, monolayer of macrophages 
were washed with PBS and then cells were fixed by addition of methanol for 15 
minutes. After two washes with PBS, cells were incubated 1 hour at 37°C with a 
polyclonal antibody anti-ASFV diluted 1:200 in PBS and then washed twice with 
PBS. Plates were viewed under an inverted fluorescent microscope (Axiovert 200, 
Zeiss, Germany). There was correspondence between viral titres obtained using 
immunofluoresce and hemadsorption.  
All the virus titres were determined using the Spearman–Kärber formula. 
Mock-virus supernatants were prepared in identical manner from uninfected Vero 
cell (‘mock Vero’) or monocyte/macrophage (‘mock macrophages’) cultures.  
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Figure 2.2 Infection of macrophages with 22653/14. Porcine blood derived 
macrophages were mock-infected (A) or infected for 24 hours with 22653/14 (B). In 
Figure B clear haemoadsorbing effects (‘rosetta’) are visible. Images taken with an 
inverted microscope (Olympus), using a 10X magnification. 
 
2.3 Enrichment of monocytes  
Peripheral blood mononuclear cells (PBMC) were prepared by layering 30 ml of 
heparinized blood diluted 2:1 in Dulbecco’s phosphate buffered saline without 
calcium and magnesium (PBS) over 20 ml of Histopaque-1077 (Sigma-Aldrich, St. 
Louis, USA) and centrifuged at 600g for 20 minutes at 4°C without breaking (Berg 
et al., 2013). PBMC were collected from the plasma-Histopaque interface, washed 
thrice in PBS at 4°C, pelleted and re-suspended in RPMI-1640 medium (Euroclone, 
Milan, Italy) supplemented with 10% FBS (Thermo Fisher Scientific, Rockford, 
USA), penicillin (100 U/ml) and streptomycin (100 μg/ml) (Pen Strep, Thermo 
Fisher Scientific, Rockford, USA) (monocyte medium).  
Porcine monocytes were isolated by plastic adhesion using flasks (Corning, NY, 
USA) pre-incubated with autologous porcine plasma, according to previous methods 
with slight modifications (Berg et al., 2013). In brief, autologous plasma was 
collected from heparinized blood by centrifugation at 700g for 30 minutes at 4°C 
without breaking. Flasks were incubated for 1 hour at 37°C with 5% CO2 with 
autologous plasma before removal of plasma and addition of PBMC. Flasks were 
B A 
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incubated for 1 hour and non-adherent cells were then removed by 4 washes with 
unsupplemented RPMI-1640 and adherent cells were incubated overnight at 37°C 
with 5% CO2 in monocyte medium. The following morning adherent cells were 
detached by placing the flasks on ice for 1 hour, pelleted by centrifugation at 200g 
for 8 minutes and re-suspended in monocyte medium; an aliquot was used to count 
and to assess cells viability using a Countess Automated Cell Counter (Thermo 
Fisher Scientific). 8-10x105 live cells/well were seeded in a 12 well plates (Greiner 
CELLSTAR, Sigma). In selected experiments a second aliquot was used to assess 
cell purity: cells were stained with CD14-PerCP (TUK4, Miltenyi Biotec, Bergisch 
Gladbach, Germany) for 10 min at room temperature (RT), washed with PBS 
supplemented with 2% FBS and resuspended in PBS. Cells were analysed using a 
FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, New Jersey, USA) 
and an average of 90% CD14+ monocytes was observed, as displayed in Figure 2.3. 
 
 
Figure 2.3 Assessment of monocyte purity using flow cytometry. Porcine blood 
derived monocytes were stained with CD14-PerCP for 10 minutes at RT, washed and 
analysed using a FACSCalibur flow cytometer. Cells with FSC and SSC typical for 
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2.4 In vitro differentiation of monocyte into moM and activation 
In Chapter 3, six different culture conditions were tested for moM differentiation. 
Monocytes were cultured for 5 days at 37°C with 5% CO2 in medium supplemented 
with different concentrations of autologous porcine plasma or human M-CSF (hM-
CSF). Plasma supplemented media were composed of RPMI-1640, 
penicillin/streptomycin (100 U/ml/100 μg/ml) and 10%, 20% or 30% (v/v) 
autologous porcine plasma, whereas hM-CSF supplemented media were prepared 
with monocyte medium and 50 ng/ml, 100 ng/ml or 200 ng/ml of recombinant 
human M-CSF (eBioscience, San Diego, USA). Porcine plasma and FBS were heat-
treated at 56°C for 30 minutes to inactivate complement before addition to culture 
media. In Chapter 4, moM differentiation was achieved by culturing monocytes for 
5 days in monocyte medium supplemented with and 50 ng/ml hM-CSF. 
To assess macrophage activation, moM obtained using 30% autologous porcine 
plasma or 50 ng/ml hM-CSF were both classically and alternatively activated as 
described in humans and pigs (Gordon and Taylor, 2005, Garcia-Nicolas et al., 2014, 
Singleton et al., 2016). In Chapter 4, only moM cultured in 50 ng/ml hMCSF were 
activated. For classical activation, moM were cultured in monocyte medium 
supplemented with 100 ng/ml of recombinant porcine IFN- (Raybiotech Inc, 
Norcross, GA, USA) and 100 ng/ml of LPS (Lipopolysaccharide from Escherichia 
coli 0111:B4; Sigma-Aldrich) for 24 hours at 37°C in 5% CO2, while for alternative 
activation, cells were stimulated with 20 ng/ml of recombinant porcine IL-4 (R&D 
Systems, Minneapolis, MN, USA) under the same culture conditions.  
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2.5 In vitro ASFV infection of monocytes/macrophages subsets and growth 
curves 
Monocytes, moMΦ, moM1 and moM2 were infected, following the replacement of 
culture media with fresh monocyte medium free of growth factors and/or cytokines, 
with the virulent 22653/14 or the attenuated BA71V ASFV strains. Monocytes and 
macrophages were infected using an MOI of 1 and mock-infected controls were 
included in every experiment. Cells were incubated at 37oC, harvested after 24 hours 
(Chapter 3) or 18 hours (Chapter 4) and infection was assessed by intracytoplasmic 
p72 expression using flow cytometry. In defined experiments, culture supernatants 
were collected to evaluate cytokine release in response to infection. To evaluate 
BA71V and 22653/14 growths in moMΦ, moM1 and moM2, cells were infected 
with an MOI of 0.01 and after 90 minutes the inoculum was removed, cells were 
washed with RPMI and fresh monocyte medium added to the wells. Culture 
supernatants were collected 0, 24, 48, 72 hours pi, cleared by centrifugation at 2000g 
for 3 minutes and stored at -80°C until analysed.  Viral titres in culture supernatants 
were determined by RT-PCR, as described below. In parallel macrophages were 
harvested and infection was confirmed by flow cytometry, as described below.  
 
2.6 Light microscopy 
Infection of Vero cells with BA71V and of monocyte/macrophages with the 
Sardinian field isolate 22653/14 were assessed by light microscopy, as displayed in 
figure 2.1 and 2.2. Differentiation of monocytes into moMΦ was observed by light 
microscopy. Monocytes were photographed immediately or were differentiated in 
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macrophages with different methods. Light microscopy was performed using an 
inverted microscope (Olympus, Tokjo, Japan), with 10X omagnification. 
 
2.7 Confocal microscopy 
Monocyte and moMΦ morphology was analysed by confocal microscopy, as 
previously described (Kyrova et al, 2014). Confocal microscopy was kindly 
performed by Dr Antonio Anfossi. Monocytes were cultured on two-well chamber 
slides (Thermo Fisher Scientific) at a concentration of 5x105 live cells/well and were 
observed immediately or following differentiation under the different culture 
conditions. In defined experiment, macrophages differentiated using 50 ng/ml of hM-
CSF were activated for 24 hours before observation. Cells were fixed with 4% 
paraformaldehyde and labelled with Hoechst 33342 (Molecular Probes, Thermo 
Fisher Scientific) for nuclear staining and Alexa Fluor 488 conjugated phalloidin 
(Molecular Probes, Thermo Fisher Scientific) to visualize actin cytoskeleton. 
Microscopy was performed using a Leica SP5 Confocal Microscope (Leica 
Microsystem, Wetzlar, Germany) equipped with a 40X Plan-Apo 1.25 NA oil 
immersion objective. Images were acquired on a format of 1024x1024 pixel, with a 
line average of 2 and scan speed of 100 Hz. Images were processed with LAS AF 
Lite software (Leica Microsystem) for contrast and brightness adjustments. 
Manipulations did not change the data content. 
 
2.8 Assessment of metabolically active cells  
A colorimetric assay based on the reduction of the MTS tetrazolium salt was used to 
assess metabolically active cells (CellTiter 96® Aqueous Non-Radioactive Cell 
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Proliferation Assay; Promega, Madison, USA). Monocytes were seeded into a 96 
well plates at a concentration of 1-2x105 live cells/well and differentiated into 
moMΦ with the six different methods as mentioned above. A control sample 
prepared with monocytes incubated in monocyte medium was also included. After 3 
days, medium was discarded, cells were washed twice with RPMI-1640 and 100 
l/well of fresh monocyte medium were added. The assay was performed, according 
to manufacturer’s instruction, and absorbance was read with an Epoch microplate 
reader (BioTek, Winoosky, VT, USA). 
 
2.9 Flow cytometry 
Expression of surface markers on porcine monocytes and moMΦ were analysed by 
multi-parameter flow cytometry. Cells were harvested with ice-cold PBS with 10mM 
EDTA, washed in PBS and transferred to a round-bottom 96 well plate (1-2 x 
105/well) for staining. To assess viability, cells were stained with LIVE/DEAD® 
Fixable Far Red Dead Cell Stain Kit (Thermo Fisher Scientific) for 30 minutes at 
4°C and washed twice with PBS supplemented with 2% FBS. Direct and indirect 
staining methods based on both unconjugated and fluorochrome-conjugated mAbs 
specific for cell surface markers were performed. The mAbs used were: MHC class 
II DR (clone 2E9/13, Bio-Rad, Oxford, UK), CD163-RPE (clone 2A10/11, Bio-
Rad), CD203a (clone PM18-7, Bio-Rad), CD14-PerCP (clone Tük4, Miltenyi Biotec, 
Bergisch Gladbach, Germany), MHC class I (JM1E3; AbD Serotec), CD16-RPE 
(G7, Thermo Scientific Pierce, Rockford, IL, USA). Primary mAbs were added to 
each well and incubated for 10 min at room temperature (RT). For indirect staining, 
secondary antibodies (Rat anti-mouse IgG2b-RPE-R&D Systems, Goat anti-mouse 
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IgG Fc cross adsorbed RPE-conjugated, Thermo Fisher Scientific) specific for the 
corresponding unconjugated primary antibody were used and allowed to incubate at 
RT for additional 10 minutes after a washing step. To complete either direct or 
indirect immunofluorescence procedures, excess of primary or secondary antibodies 
were washed away with PBS. For control staining, the following irrelevant isotype-
matched control antibodies were employed: mouse IgG1 isotype control PE 
conjugated (clone ZX3, Thermo Fisher Scientific), mouse IgG1 negative control 
purified, mouse IgG2b negative control purified (Bio-Rad). To assess ASFV 
infection, intracytoplasmic staining was performed. Cells were fixed and 
permeabilized using Leucoperm (Bio-Rad) according to manufacturer’s suggestion. 
Afterwards cells were incubated with mAbs at RT for 30 minutes in the dark. mAbs 
used for intracellular staining were: anti-p72-FITC (18BG3, Ingenasa) and p30-FITC 
(kindly provided by Dr Gian Mario De Mia, IZSUM, Italy). Cells were washed twice 
in PBS, re-suspended in PBS and transferred to FACS tubes prior to flow cytometric 
analysis. All the washes used centrifugation at 836g for 3 minutes. All antibodies 
used for flow cytometric analysis are listed in Table 2.1. At least 5000 live 
monocytes/moMΦ were acquired on a FACS Calibur (FACS Calibur, BD, Franklin 
Lakes, USA) flow cytometer and analysed using Cell Quest Pro software (BD). 
Analysis of data was performed by gating on viable cells (Live/Dead Fixable Dead 
Cell Stain negative) in the monocyte/macrophage population, and their expression of 
surface and intracytoplasmic markers was assessed. Gates for surface markers were 
set using the corresponding isotype controls, whereas gates for ASFV proteins were 
set using the mock-infected controls. 
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2.10 TNF- release in response to LPS stimulation 
Analysis of TNF- secretion from monocytes and moMΦ in response to LPS 
stimulation was also performed. Briefly, culture media were discarded and replaced 
with fresh monocyte medium, then cells were stimulated with 100 ng/ml of LPS. 
Unstimulated cells were used as a negative control. After 6 hours of culture, 
supernatants were collected, cleared by centrifugation at 2000g for 3 minutes and 
stored at -80°C until analysed. The measurement of TNF- levels in culture 
supernatants was performed using a Porcine TNF- Duoset ELISA (R&D System), 
according to the manufacturer’s instructions and absorbance was read with an Epoch 
microplate reader (BioTek). 
 
2.11 Patterns of cytokine secretion  
Analysis of basal cytokine release from moMΦ differentiated in different media or in 
response to classical and alternative activation or after ASFV infection was 
performed using a multiplex immunoassay. Monocytes were seeded in 12 well plates 
and differentiated into moMΦ under the different conditions as described above. 
After 5 days, supernatants were collected, cleared by centrifugation at 2000g for 3 
minutes and stored at -80°C until analysed. MoMΦ cultured in 30% autologous 
plasma or 50 ng/ml hM-CSF were left untreated or classically and alternatively 
activated. After 24 hours activation, supernatants were collected, cleared by 
centrifugation at 2000g for 3 minutes and stored at -80°C until analysed.  
Analysis of cytokine release in response to ASFV infection was also assessed. 
Monocytes and macrophage subsets were infected with the avirulent BA71V or the 
virulent 22653/14 strains, alongside with mock-infected controls. 18 hours pi, 
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supernatants were collected, cleared by centrifugation at 2000g for 3 minutes and 
stored at -80°C until analysed.  
The simultaneous measurement of GM-CSF, IL-1, IL-1, IL-RA, IL-2, IL-4, IL-6, 
IL-8, IL-10, IL-12, IL-18 and TNF-α was performed using the Porcine 
Cytokine/Chemokine Magnetic Bead Panel Quantikine kit (Merck Millipore, 
Darmstadt, Germany) and a Bioplex MAGPIX Multiplex Reader (Bio-Rad, 
Hercules, CA, USA), according to the manufacturer’s instructions. In defined 
experiments, only the levels of IL-1α, IL-1β, IL-1RA, IL-6, IL-10, IL-12 and TNF-α 
were assessed. These experiments were kindly performed by Dr Silvia Dei Giudici, 
Dr Piero Bonelli and Susanna Zinellu. The intra-assay and inter-assay CV were 10% 
and 20%, respectively. 
 
2.12 DNA extraction and real-time PCR 
Viral DNA was extracted from cell culture supernatants using High Pure PCR 
Template Preparation Kit according to the manufacturer’s protocols (Roche, 
Mannheim, Germany). ASFV viral copy numbers were assessed by real-time PCR 
(King et al., 2003), using the TaqMan Fast Advanced Master Mix (Applied 
Biosystems), 0.8 µM of sense and anti-sense primers (5’-CTG CTC ATG GTA TCA 
ATC TTA TCG A-3’and 5’-GAT ACC ACA AGA TCR GCC GT-3’), 0.2 µM of 
TaqMan probe 5’-[6-carboxy-fluorescein (FAM)]-CCA CGG GAG GAA TAC CAA 
CCCAGT G-3’-[6-carboxy-tetramethyl-rhodamine (TAMRA)] in a total volume of 
25 µl containing 5 µl of extracted DNA. The incubation profile was established as 
follows: 40 cycles of denaturation at 95°C for 15’’, annealing at 58°C for 60”, after a 
initial denaturation step at 95°C for 10’. The plasmid pEX-K4-ASFV-E70p72 
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(Eurofins Genomics, USA) was used as the template to prepare the standard curve 
for the real-time PCR assay. This plasmid contains a full length p72 sequence and the 
copy number was calculated based on the plasmid and insert molecular weight. For 
each experiment, a standard curve was prepared by serial dilution (10+8-10+1) of 
pEX-K4-ASFV-E70p72 template DNA. These experiments were kindly performed 
by Dr Silvia Dei Giudici and Martina Sale.  
 
2.13 Data analysis and statistics 
All experiments were performed in duplicates (for metabolic activity assay and 
multiplex cytokine immunoassay) or triplicates (all other assays), and repeated at 
least three times with different blood donor pigs. Graphical and statistical analysis 
was performed using GraphPad Prism 5.04 (GraphPad Software Inc, La Jolla, USA). 
Data were presented as boxplots, indicating the median (middle line), 25th and 75th 
percentiles (boxes), maximum and minimum (whiskers), or as means with standard 
deviations (SD) quoted to indicate the uncertainty around the estimate of the group 
mean. A Mann-Whitney test or a one-way analysis of variance (ANOVA) followed 
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Table 2.1 Antibodies used for flow cytometric analysis of surface and 
intracellular markers of porcine myeloid cells 






































































Mouse Pig IgG2b 0.1 None 1/40 














Rat Mouse IgG1 ND PE 1/10 
Goat anti-














0.5 RPE 1/80 
         
ND: not determined. 
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CHAPTER 3. RESULTS: IN VITRO DIFFERENTIATION OF PORCINE 
MONOCYTES INTO MACROPHAGES 
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3.1 Introduction 
moM have been employed as a model cell in numerous studies of the porcine 
immune system. However, the lack of a standardized method for moMΦ 
differentiation hampers the comparison of results coming from the use of different 
laboratory protocols. In the first phase of the work, we sought to determine the 
optimal method for porcine moM generation by directly comparing the phenotype 
and function following differentiation induced by different protocols. The use of 
varying concentrations of autologous plasma (10, 20 and 30% v/v) or recombinant 
human macrophage-colony stimulating factor (hM-CSF; 50, 100, and 200 ng/ml) to 
differentiate porcine monocytes into macrophages were compared. Changes in cell 
morphology and surface marker expression were assessed by confocal microscopy 
and flow cytometry. Macrophage differentiation was evaluated by analysing TNF-α 
response to LPS stimulation and determining cytokine secretion patterns under both 
basal conditions and after classical and alternative activation. The effects of the 
differentiation methods on metabolic activity and susceptibility to infection with the 
myelotropic ASFV were also evaluated.  
 
3.2 Phenotype characterization of moMΦ 
First, changes in cell morphology were evaluated by flow cytometry and confocal 
microscopy. As displayed in Figure 3.1, moMΦ differentiated by both autologous 
plasma (AP-moM) and hM-CSF (M-CSF-moM) increased significantly in 
dimension and granularity compared to monocytes, as respectively shown by their 
forward (FSC) and side angle (SSC) light scattering properties measured by flow 
cytometry. No significant differences were observed between moMΦ populations in 
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terms of FSC, instead SSC was increased in AP-moMΦ compared to M-CSF-
moMΦ. Increasing porcine plasma concentrations produced a dose dependent 
increase in granularity as shown by the SSC values. Confocal microscopy showed 
that AP-moMΦ appeared more pleomorphic and presented an increased number of 
elongated projections protruding from cell surfaces compared to M-CSF-moMΦ, as 
represented in Figure 3.2. 
Changes in surface marker expressions were then evaluated by flow cytometry. 
moMΦ differentiation by either method induced a cell surface immunophenotype 
significantly dissimilar from monocytes, with a significant up-regulation in 
expression of CD163, MHC-II DR and CD203a, as shown in Figure 3.3. CD163 was 
more highly expressed in M-CSF-moMΦ compared to AP-moMΦ. Percentages of 
MHC-II DR+ and CD203a+ cells were similar between protocols with the only 
exception of moMΦ differentiated with 30% of autologous plasma, which presented 
significantly higher proportions of CD203a+ cells compared to M-CSF-moMΦ. 
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Figure 3.1. Morphological analyses of monocytes and moM populations using 
flow cytometry. Blood derived monocytes were analysed immediately or 
differentiated into macrophages through incubation with 10, 20 or 30% (v/v) of 
porcine plasma, or using 50, 100 or 200 ng/ml of hM-CSF for 5 days at 37°C in 5% 
CO2. Differences between populations in terms of dimension (FSC, forward scatter) 
and complexity (SSC, side scatter) were evaluated using flow cytometry. Boxplots 
indicate the median (middle line), 25th and 75th percentiles (boxes), maximum and 
minimum (whiskers) of FSC/SSC of three independent experiments performed in 
triplicate. Values for each marker were compared using an ANOVA followed by a 
Kruskall-Wallis test. Different letters indicate significant differences between moM 
populations (p<0.05). 
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Figure 3.2. Morphological analyses of moM populations using confocal 
microscopy. Blood derived monocytes were differentiated into macrophages through 
incubation with 10, 20 or 30% (v/v) of porcine plasma, or using 50, 100 or 200 ng/ml 
of hM-CSF for 5 days at 37°C in 5% CO2. Confocal microscopy observations after 
staining nuclei in blue with Hoechst 33342 and cytoskeleton in green with Alexa 
Fluor 488-conjugated Phalloidin. Magnifications are 40X. 
 
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  




Figure 3.3. Expression of cell surface markers by monocytes and moM 
populations. Monocytes and moM populations were analysed for surface markers 
expression and differences between monocytes and moM populations in terms of 
CD163, MHC II-DR and CD203a are displayed. Representative dot plots of 
monocytes and moM differentiated using 30% of plasma or 50 ng/ml of h M-CSF 
are shown. Boxplots indicate the median (middle line), 25th and 75th percentiles 
(boxes), maximum and minimum (whiskers) of positive cells of three independent 
experiments performed in triplicate. Values of MHC II-DR, CD163 and CD203a 
expression were compared using a a Mann-Whitney Test. Different letters indicate 
significant differences between moM populations (p<0.05). 
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3.3 Assessment of metabolically active cells  
The metabolic activity of different moM populations was evaluates using the 
CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay. As displayed in 
Fig 3.4, moMΦ differentiated using hM-CSF as well as 20% and 30% of autologous 
porcine plasma showed enhanced metabolic activity compared to monocytes cultured 
using monocyte medium (RMPI + antibiotics + 10% FBS) alone. M-CSF-moMΦ, 
and the 200 ng/ml cultures in particular, presented increased activity compared to 
AP-moMΦ. Significant differences in the metabolic activity were also found between 
macrophages produced with 10% compared to 30% of autologous plasma. 
 
Figure 3.4 Assessment of the metabolic activity of moM populations. 
Monocytes were seeded into a 96 well plate and differentiated into moM through 
incubation with un-supplemented monocyte medium (RMPI + antibiotics + 10% 
FBS; ‘none’) or in media supplemented with 10-20-30% (v/v) porcine plasma or 
monocyte medium with 50-100-200 ng/ml of hM-CSF for 3 days at 37°C in 5% 
CO2. Metabolic activity was determined using the CellTiter 96® Aqueous Non-
Radioactive Cell Proliferation Assay. Background absorbance was subtracted and 
graph represents the mean data +/- SD from three independent experiments utilizing 
different animals. Values were compared using ANOVA followed by a Kruskall-
Wallis test. Different letters indicate significant differences between moM 
populations (p<0.05). 
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
3.4 Susceptibility to ASFV  
The susceptibility of moMΦ differentiated with the different techniques to ASFV 
infection was also analysed. The intracytoplasmic expression of late ASFV p72 
protein was measured to evaluate if the differentiation method could influence viral 
tropism. Our results showed that all moMΦ populations expressed p72 at higher 
levels compared to monocytes, with minimal differences being observed between 
moMΦ differentiated using the different culture conditions (Figure 3.5). Using 30% 
of autologous plasma a slightly lower susceptibility to ASFV infection was observed 
(Figure 3.5). 
 
3.5 LPS-stimulated release of TNF- 
The ability to release TNF- in response to LPS stimulation was also determined. As 
displayed in Figure 3.5, all the six moMΦ populations displayed increased TNF- 
production compared to monocytes. MoMΦ differentiated using 200 ng/mL M-CSF 
secreted the greatest amount of TNF-α. No significant differences between those 
cultured in 50, 100 ng/mL M-CSF and 30% of porcine plasma were found. 
Macrophages differentiated in 10% of porcine plasma produced the lowest amount of 
TNF-α (Figure 3.5).  
 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  










a a a a a a a
f








































Figure 3.5. Susceptibility to ASFV infection and TNF-α release in response to 
LPS stimulation by monocytes and moM. On the top, susceptibility to ASFV is 
displayed. Monocytes and moM populations were mock-infected or infected with 
the virulent ASFV isolate 22653/14 using a MOI of 1. 24 hours pi cells were 
harvested and infection was evaluated by intracytoplasmic detection of the viral p72 
in flow cytometry. The mean data ± SD from three independent experiments utilizing 
different animals are shown. Below, TNF- release in response to LPS stimulation is 
displayed. Monocytes and moM differentiated with different methods were left 
untreated or stimulated with 100 ng/ml of LPS for 6 hours. Supernatants were 
collected and stored at -80°C till analysis. The mean data +/- SD from five 
independent experiments utilizing different animals are shown. TNF- amounts in 
culture supernatants were evaluated using an ELISA assay. For both panels, 
differences between groups were compared using an ANOVA followed by a 
Kruskall-Wallis test. Different letters indicate significant differences between moM 
populations (p<0.05). 
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3.6 Patterns of cytokine secretion 
The basal release of a panel of cytokines from moMΦ differentiated under the 
different culture conditions was assessed using a multiplex immunoassay. No 
differences in the levels of IL-1, IL-1, IL-6, TNF- were observed between 
macrophage populations (data not shown). Instead statistically significant differences 
were detected in the levels of IL-10, IL-12, IL-1RA (Figure 3.6). MoMΦ 
differentiated using 100 and 200 ng/mL hM-CSF released a statistically significantly 
higher amount of IL-10 compared to AP-moMΦ. Instead the supernatants of AP-
moMΦ contained statistically significant higher amounts of IL-12, but this was also 
present in the background control (RPMI-1640 supplemented with 30% of porcine 
plasma), suggesting that the IL-12 was derived from the autologous plasma as 
opposed to being released by the AP-moMΦ. Higher levels of IL-1RA were detected 
in the supernatant of AP-moMΦ compared to M-CSF-moMΦ or the background 
control.  
Finally, differences in the ability of moMΦ produced under selected differentiation 
culture conditions (30% of plasma and 50 ng/ml of hM-CSF) to respond to classical 
and alternative activation were assessed. Differentiating cells under these conditions 
resulted in the same levels of metabolic activity (Figure 3.4) and so ensured that the 
number of live cells in culture would not influence the results. Culture media was 
discarded before macrophage stimulation. As represented in Figure 3.7, using both 
protocols, classical activation resulted in release of IL-12 and pro-inflammatory 
cytokines IL-1, IL-1, IL-6, TNF- Higher levels of IL-1, IL-1, TNF- were 
observed in moM1 derived from 50 ng/ml M-CSF-moMΦ compared to 30% AP-
moMΦ, instead there were no differences in the other cytokines tested. Almost 
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undetectable levels of cytokines were observed after alternative activation of either 
moMΦ population. 
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Figure 3.6. Basal cytokine release from moM differentiated in different 
culture conditions. Blood derived monocytes were differentiated into moM 
through incubation with 10, 20 or 30% (v/v) of porcine plasma, or using 50, 100 or 
200 ng/ml of hM-CSF for 5 days at 37°C in 5% CO2. IL-1α, IL-1β, IL-RA, IL-6, IL-
10, IL-12 and TNF-α in culture supernatants and background control (BKG) were 
evaluated using a Porcine Cytokine/Chemokine Magnetic Bead Panel Quantikine, 
according to manufacturer’s protocol. The mean data +/- SD from three independent 
experiments utilizing different animals are shown. Values for each cytokine were 
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compared using an ANOVA followed by a Kruskall-Wallis test. The different letters 





















































































Figure 3.7. Cytokines release by classically and alternatively activated moM. 
MoM differentiated through incubation with 30% (v/v) of porcine plasma (white 
bar) and using 50 ng/ml of hM-CSF (black bar) were both classically (moM1) and 
alternatively (moM2) activated. For classical activation macrophages were 
stimulated with 100 ng/ml of recombinant porcine IFN- and 100 ng/ml of LPS 
while for alternative activation with 20 ng/ml of recombinant porcine IL-4 for 24 
hours at 37°C in 5% CO2. IL-1α, IL-1β, IL-RA, IL-6, IL-10, IL-12 and TNF-α were 
detected in culture supernatants using a Porcine Cytokine/Chemokine Magnetic Bead 
Panel Quantikine, according to manufacturer’s protocol. The mean data +/- SD from 
three independent experiments utilizing different animals are shown. Values for each 
cytokine were compared using a Mann-Whitney Test. Different letters indicate 
significant differences between macrophage populations (p<0.05). 
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CHAPTER 4. RESULTS: CHARACTERIZATION OF THE INTERACTION 
OF ASFV WITH MONOCYTES AND MACROPHAGE SUBSETS 
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4.1 Introduction  
ASFV mainly targets cells of the myeloid lineage, especially monocytes and 
macrophages, thought to be crucial for viral persistence and dissemination (Sierra et 
al., 1991, Sánchez-Cordón et al., 2008). Infection with virulent ASFV isolates 
evolves towards cell lysis at very late time of infection (Breese and DeBoer, 1966), 
since they express proteins (such as A224L, A179L, EP153R) that prevent apoptosis, 
allowing infected cells to survive and disseminate the virus through the body (Nogal 
et al., 2001, Galindo et al., 2008, Hurtado et al., 2004). On the contrary, the avirulent 
tissue-culture adapted BA71V strain is able to infect macrophages and to synthesise 
viral late proteins, but induces early cell death, preventing the production of 
infectious viral progeny (Zsak et al., 2001).  
To date few studies analysed the effects of ASFV on monocytes and macrophages in 
terms of their expression of surface markers (Sánchez-Torres et al., 2003, Lithgow et 
al., 2014) or cytokine and chemokine responses (Gómez del Moral et al., 1999, Gil et 
al., 2008,  Gil et al., 2003, Zhang et al., 2006, Fishbourne et al., 2013) and none have 
compared responses of activated macrophage subsets. Considering the central role of 
M for ASFV pathogenesis and the effects of classical and alternative activation on 
M, it was tested if cells in distinct activation statues reacted differently to ASFV, 
with differences between isolates varying in virulence. Virulent isolates might have 
developed mechanisms to affect activated macrophages responses, to promote their 
survival and dissemination in the host. To address these questions, in the second part 
of the work a detailed in vitro analysis of the interaction of monocytes and derived 
macrophage subsets with a virulent (22653/14) and an avirulent (BA71V) ASFV 
strains was conducted. 
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4.2 Generation of monocyte-derived macrophage subsets 
Considering the results generated in the first phase of the work, porcine moMwere 
generated by culturing porcine monocytes in media supplemented with 50 ng/ml of 
hM-CSF for 5 days. These cells were activated by the classical or alternative method 
for a further 24 hours. Monocytes differentiation into macrophages and their 
activation was assessed by confocal microscopy and flow cytometry, as displayed in 
figure 4.1 and 4.2. All monocyte–derived macrophage subsets were larger than their 
monocyte precursors and presented with a spherical shape with short hairy 
protrusions on their surface (Figure 4.1A). In addition, they presented higher 
dimension (forward scatter; FSC) and granularity (side scatter; SSC) as well as 
expressed higher levels of CD163, and MHC II-DR than monocytes (Figure 4.1B 
and 4.2). No differences in terms of dimension (FSC) and granularity (SSC) were 
observed between macrophage subsets, whereas these populations differed in terms 
of surface markers expression. In accordance with previous studies (Garcia-Nicolas 
et al., 2014), classical  activation induced increase in the MHC II-DR expression, and 
IL-4 pre-treatment resulted in a little reduction of the MFI of CD163 (Figure 4.1B).  
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Figure 4.1. Differentiation of monocytes into macrophage subsets. Blood derived 
monocytes were analysed directly or differentiated into macrophages using hM-CSF. 
Un-activated macrophages (moM) were left un-treated or activated for 24 hours in 
a classical (IFN- and LPS, moM1) or alternative (IL-4, moM2) way. Differentiation 
of monocytes into macrophages and their activation was morphologically assessed 
by confocal microscopy (original magnification 40X) (A). Differences between 
monocytes and derived macrophage subsets in terms of FSC (forward scatter), SSC 
(side scatter) and expression of CD163 and MHC II-DR were assessed by flow 
cytometry (B). The mean data +/- SD from three independent experiments utilizing 
different animals are shown. Values were compared using a one-way ANOVA 
followed by a Kruskal-Wallis test; ***p<0.001, **p<0.01, *p<0.05.  
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Figure 4.2 Representative dot plots of monocytes and derived macrophage 
subsets. Differences between monocytes and monocyte-derived macrophage subsets 
in terms of FSC (forward scatter), SSC (side scatter) and expression of CD163 and 
MHC II-DR were assessed by flow cytometry. In panel A gating strategy used to 
investigate surface marker expression on monocytes/macrophages are displayed: 
cells with FSC and SSC typical for monocytes/macrophages and viable (Live/Dead 
Fixable Dead Cell Stain-) were analysed for surface expression of surface markers. 
Gating were set by comparing staining with an isotype control mAb. In panel B 
representative dot plots of monocytes and macrophage subsets are displayed. Below 
each plot, MFI values for SSC/FSC or surface markers are reported, while inside 
each plot % of CD163+ or MHC II-DR+ cells are indicated. 
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4.3 Monocytes and macrophage subsets susceptibility to ASFV infection 
Susceptibility of monocytes and macrophage subsets to ASFV infection was assessed 
by quantification of the intracellular levels of the late protein p72 by flow cytometry, 
using the gating strategy displayed in Figure 4.3A. Cells were mock-infected or 
infected with the tissue-culture adapted BA71V or the virulent Sardinian isolate 
22653/14, using a MOI of 1. As displayed in Figure 4.3, for both isolates, 
macrophages were more susceptible to ASFV infection than freshly isolated 
monocytes. Classical activation resulted in a higher resistance to ASFV infection, 
with differences between isolates varying in virulence, whereas for both BA71V and 
22653/14 similar levels of p72 proteins were observed between moM and moM2. 
22653/14 presented greater ability to infect monocytes and moM1 than the avirulent 
strain, in fact only 5-10% of p72+ monocytes and moM1 were detected after BA71V 
infection (Figure 4.3). Using a MOI of 1, after 22653/14 infection, statistically 
significant differences between moM and moM1 were observed only in some of 
the pig analysed (data not shown). In order to check if the differences observed 
between 22653/14 and BA71V in monocytes and moM1 were due to inhibition to 
viral protein synthesis, levels of the early protein p30 in monocytes and macrophage 
subsets were evaluated (Figure 4.4). Despite differences observed between BA71V 
and 22653/14 infected monocytes in terms of p72, the same levels of p30+ cells were 
detected in monocytes infected with these strains. Whereas, as displayed in Figure 
4.4, 22653/14 infection resulted in higher levels of p30+ moM1 than BA71V.  
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Figure 4.3. Susceptibility to infection by monocytes and derived macrophage 
subsets. Monocytes and macrophage subsets were infected with the avirulent 
BA71V or virulent 22653/14 ASFV strain using a MOI of 1, alongside mock-
infected control. 18 hours post-infection cells were harvested and % of p72+ cells and 
MFI of p72 were evaluated using flow cytometry. In Panel A gating strategy used to 
investigate ASFV infection on live monocytes/macrophages is displayed: cells with 
FSC and SSC typical for monocytes/macrophages and viable (Live/Dead Fixable 
Dead Cell Stain-) were analysed for their intra-cytoplasmic levels of late viral ASFV 
protein p72; gating were set by comparing staining with mock-infected controls. In 
Panel B representative dot plots of BA71V-infected or 22653/14-infected monocytes, 
moM, moM1, moM2 are displayed. In Panel C the mean data +/- SD from five 
independent experiments utilizing different animals are shown. For each virus-
stimulated conditions values of activated macrophages (moM1 and moM2) were 
compared to the corresponding un-activated control (moM), using a one-way 
ANOVA followed by a Kruskal-Wallis test; ***p<0.001, **p<0.01, *p<0.05.  
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Figure 4.4 Expression of the early protein p30 in ASFV-infected monocytes and 
macrophage subsets. Monocytes, un-activated (moM), classically (moM1) and 
alternatively (moM2) activated macrophages were infected with the avirulent 
BA71V strain or with the virulent 22653/14 field strain using a MOI of 1. Mock-
infected control cells were included for each cell type. 18 hours pi cells were 
harvested and percentages of p30+ cells and MFI of p30 were evaluated using flow 
cytometry. The mean data +/- SD from three independent experiments utilizing 
different animals are shown. Values of activated macrophages (moM1 and moM2) 
were compared to the corresponding un-activated control (moM), using a one-way 
ANOVA followed by a Kruskal-Wallis test; ***p<0.001, **p<0.01, *p<0.05. 
Differences in the p30 expression between BA71V and 22653/14 were compared 




Then it was assessed if pre-treatment of macrophages with IFN-or LPS alone was 
able to reduce susceptibility to ASFV. Activation with these cytokine alone 
decreased BA71V but not 22653/14 infection (Figure 4.5). In addition, pre-treatment 
of macrophages with M1-polarizing factors resulted in a lower expression of the 
early ASFV protein p30 in BA71V but not 22653/14 infected cells (Figure 4.5). 
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Figure 4.5 Different expression of early and late proteins in macrophages 
activated with IFN-g +/- LPS. Un-activated macrophages (moM) were left 
untreated or activated with IFN- or/and LPS for 24 hours and then mock-infected or 
infected with the avirulent BA71V or the virulent field isolate 22653/14. 18 hours 
post-infection cells were harvested and expression of p30 and p72 were assessed by 
flow cytometry. The mean data +/- SD from three independent experiments utilizing 
different animals are shown. Representative dot plots of ASFV-infected un-activated 
and activated macrophages are displayed and below the effect of macrophage 
activation with IFN- +/- LPS on expression of p30 and p72 ASFV proteins is 
reported. Values of activated macrophages were compared to the corresponding un-
activated control (moM), using a one-way ANOVA followed by a Kruskal-Wallis 
test; ***p<0.001, **p<0.01, *p<0.05.  
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4.4 ASFV growth in macrophage subsets 
A kinetic analysis of BA71V and 22653/14 replication in moM, moM1 and moM2 
was conducted by assessing the intracellular levels of p30 and p72 with flow 
cytometry and the viral copies number in cells supernatants with RT-PCR. As 
displayed in Figure 4.6, using a MOI of 0.01, 24 hours pi with the virulent 22653/14 
both moM1 and moM2 displayed lower levels of ASFV proteins than moM, but at 
48 hours pi almost all (around 90%) of the live un-activated and activated 
macrophages were p30+ or p72+. 72 hours pi it was not possible to acquire 5000 live 
macrophages in flow cytometry, since the majority of infected macrophages were 
dead. Using a MOI of 0.01, very low levels of ASFV proteins were detected after 
infection with the attenuated BA71V strain, even 48 hours pi. 24 hours pi, moM2 
displayed little but statistically significantly higher levels of both p30 and p72 
proteins than other macrophage subsets, not observed at the later time point. At each 
time points (0, 24, 48, 72 hours pi), the viral copies numbers in culture supernatants 
were evaluated. As displayed in Figure 4.6, using a MOI of 0.01 even 72 hours pi 
with the avirulent BA71V a very low number of viral copies were detected in culture 
supernatants. Nevertheless, a statistically significant higher number of viral copies 
was observed in moM2 culture supernatants at 48 and 72 hours pi. On the contrary, 
using a MOI of 0.01 the virulent 22653/14 isolate was able to actively replicate in all 
the macrophage subsets, with high levels of viral copies detected 72 hours pi. Despite 
differences in the percentages of ASFV viral proteins detected 24 hours pi using flow 
cytometry, no statistically significant differences between macrophage populations in 
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terms of viral proteins in culture supernatants were observed at any time pi (Figure 
4.6).  
 
Figure 4.6 Growth characteristic of the ASFV strains on different macrophage 
subsets. Un-activated (moM), classically (moM1) and alternatively (moM2) 
activated macrophages were infected with the avirulent BA71V or the virulent 
22653/14 ASFV strains, using a MOI of 0.01. After 1.5 hour of incubation cells were 
washed twice and cultured in fresh monocyte medium. At 0, 24, 48, 72 hours pi 
triplicate samples were collected: intracytoplasmic levels of p30 and p72 were 
assessed by flow cytometry. In parallel, at each time points the viral levels in culture 
supernatants were assessed by qPCR. The mean data +/- SD from three independent 
experiments utilizing different animals are shown. At each time-point values for 
moM1 and moM2 were compared to the corresponding un-activated control 
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(moM), using a one-way ANOVA followed by a Kruskal-Wallis test; ***p<0.001, 
**p<0.01, *p<0.05.  
 
4.5 Effect of ASFV infection on surface marker expression on monocytes and 
derived macrophage subsets 
The effect of ASFV infection on expression of CD16, MHC I, MHC II, CD163 was 
assessed using flow cytometry, analysing differences between BA71V and 22653/14 
strains and comparing infected cells with both uninfected bystander and mock-
infected cells (Figure 4.7). Because the levels of p72+ monocytes and moM1 after 
BA71V infection using a MOI of 1 were less than 10% (Figure 4.3), it was unreliable 
to compare infected and bystander cells for these subsets. First it was assessed the 
effect of mock-infection with a Vero cell lysate and a monocyte-macrophage cell 
lysate for 18 hours on the expression of CD16, MHC II, MHC I and CD163. No 
differences in marker expression levels between the ‘mock Vero’ or ‘mock 
monocyte-macrophage’ infection and cells cultured in monocyte medium (data not 
shown) were observed, and consequently mock-infection controls were performed 
using monocyte medium. As displayed in Figure 4.7 and 4.8, ASFV infection down-
regulated the expression of CD16 in porcine monocytes and macrophage subsets. 
Statistically significant differences in the % of positive cells were observed between 
infected and both uninfected bystander and mock-infected cells. Infected cells 
showed a lower MFI of positive cells compared to the mock-controls. MHC I levels 
on monocytes/macrophages did not change after 22653/14 infection, instead BA71V-
infected moM and moM2 had a lower expression (both percentages and MFI) of 
this marker than bystander and mock-infected cells (Figure 4.7 and 4.9). Very little 
difference in MHC II percentages were also detected between infected and bystander 
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monocytes and moM2, but not correlated with their MFI (Figure 4.7 and 4.10). As 
displayed in Figure 4.7 and 4.11, for both strains infected and bystander 
monocytes/macrophages displayed similar percentages of CD163+ cells. However 
after infection with BA71V both bystander and infected monocytes, moM and 
moM2 displayed lower levels of CD163 compared to the mock-infected controls. 
Infection with the virulent 22653/14 virus did not affect CD163 expression in 
macrophages, nevertheless little but statistically significant differences were 
observed in the MFI of positive cells between 22653/14-infected and mock-infected 








 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
 
Figure 4.7. Effect of ASFV on the surface markers expression of monocytes and 
macrophage subsets. Monocytes, un-activated (moM), classically (moM1) and 
alternatively (moM2) activated macrophages were infected with the attenuated 
BA71V or the virulent 22653/14 strain using a MOI 1, alongside mock-infected 
controls. 18 hours pi, cells were harvested and expression of p72 and surface markers 
(CD16, MHC II, MHC I, CD163) were evaluated using flow cytometry. The mean 
data +/- SD from three independent experiments utilizing different animals are 
shown. Differences between mock-infected (white) and BA71V-bystader (black), 
BA71V-infected (horizontal bars), 22653/14-bystander (vertical bars), 22653/14-
infected (oblique bars) cells for each marker were evaluated. On the right, 
differences in terms of % of positive cells are displayed, while on the left MFI of 
positive cells are reported. Values for each virus-stimulated condition were compared 
to the corresponding un-stimulated control (mock) using a one-way ANOVA 
followed by a Kruskal-Wallis test; ***p<0.001, **p<0.01, *p<0.05.  
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Figure 4.8. Effect of ASFV on CD16 expression of monocytes and macrophage 
subsets. Monocytes, un-activated (moM), classically (moM1) and alternatively 
(moM2) activated macrophages were infected with the attenuated BA71V strain or 
with the virulent 22653/14 field strain using a MOI 1. Mock-infected control cells 
were included for each cell type. 18 hours pi, cells were harvested and expression of 
p72 and CD16 were evaluated using flow cytometry. For each mock or virus-
stimulated condition representative dot plots of monocytes, moM, moM1 and 
moM2 are displayed.  
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Figure 4.9. Effect of ASFV on MHC I expression of monocytes and macrophage 
subsets. Monocytes, un-activated (moM), classically (moM1) and alternatively 
(moM2) activated macrophages were infected with the attenuated BA71V strain or 
with the virulent 22653/14 field strain using a MOI 1. Mock-infected control cells 
were included for each cell type. 18 hours pi, cells were harvested and expression of 
p72 and MHC I were evaluated using flow cytometry. For each mock or virus-
stimulated condition representative dot plots of monocytes, moM, moM1 and 
moM2 are displayed.  
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Figure 4.10. Effect of ASFV on MHC II-DR expression of monocytes and 
macrophage subsets. Monocytes, un-activated (moM), classically (moM1) and 
alternatively (moM2) activated macrophages were infected with the attenuated 
BA71V strain or with the virulent 22653/14 field strain using a MOI 1. Mock-
infected control cells were included for each cell type. 18 hours pi, cells were 
harvested and expression of p72 and MHC II-DR were evaluated using flow 
cytometry. For each mock or virus-stimulated condition representative dot plots of 
monocytes, moM, moM1 and moM2 are displayed.  
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Figure 4.11. Effect of ASFV on CD163 expression of monocytes and 
macrophage subsets. Monocytes, un-activated (moM), classically (moM1) and 
alternatively (moM2) activated macrophages were infected with the attenuated 
BA71V strain or with the virulent 22653/14 field strain using a MOI 1. Mock-
infected control cells were included for each cell type. 18 hours pi, cells were 
harvested and expression of p72 and CD163 were evaluated using flow cytometry. 
For each mock or virus-stimulated condition representative dot plots of monocytes, 
moM, moM1 and moM2 are displayed.  
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4.6 Production of cytokines in ASFV-infected monocytes/macrophage subsets 
Finally, the cytokine responses of monocytes and macrophage subsets to BA71V and 
22653/14 were investigated. First it was assessed if mock-infection with clarified 
Vero cell or monocyte-macrophage cell lysates for 18 hours induced cytokine 
responses. Since no differences between co-culture with ‘mock Vero’ or ‘mock 
monocyte-macrophage’ and monocytes medium in the levels of GM-CSF, IL-1, IL-
1, IL-2, IL-4, IL-6, IL-10, IL-12, IL-18, TNF- (data not shown) were detected, 
monocyte medium was used as the negative control in subsequent experiments. No 
statistically significant GM-CSF, IL-2, IL-4, IL-6, IL-10, IL-12 or TNF- responses 
were observed from monocytes and derived macrophage subsets infected with either 
strain (data not shown). Instead differences were observed in the levels of IL1-, IL-
1 and IL-18: moM1 released higher levels of IL1-, IL-1 and IL18 in response to 
BA71V infection compared to uninfected control (Figure 4.12). Differences were 
also observed in the levels of IL-1 between mock-infected and BA71V-infected 
monocytes and in the levels of IL-1 between mock-infected and BA71V-infected 
moM2 and monocytes, albeit the latter difference was without statistical significance 
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Figure 4.12. Investigation of cytokines release by monocytes and macrophage 
subsets in response to ASFV infection. Monocytes, un-activated (moM), 
classically (moM1) and alternatively (moM2) activated macrophages were infected 
with the attenuated BA71V strain or with the virulent 22653/14 field strain using a 
MOI of 1. Mock-control cells were included for each cell type. 18 hours pi, the levels 
of IL-1, IL-1 and IL-18 in culture supernatants were evaluated. The mean data +/- 
SD from three independent experiments utilizing different animals are shown. Values 
for MOCK (white), BA71V (black) and 22653/14 (horizontal bars) were compared 




















 Giulia Franzoni 
‘Interaction of monocytes and derived macrophage subsets with African swine fever viruses of diverse virulence’ 
International PhD Course in Life Sciences and Biotechnologies  
University of Sassari 
 
CHAPTER 5. DISCUSSION 
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As previously stated, the first phase of the work focused on the identification of the 
optimal method to in vitro differentiate porcine monocyte into moM. MoMΦ have 
been utilised in numerous studies of the porcine immune system, especially in the 
context of myelotropic viruses such as ASFV and PRRS (Thacker et al., 1998, 
Sanchez-Torres et al., 2003, Vincent et al., 2005, Fishbourne et al, 2013, Garcia-
Nicolas et al., 2014, Singleton et al, 2016), but currently there is no standardized 
protocol for their generation. The availability of a reliable standard technique would 
add value to efforts to both understand basic porcine macrophage biology and to 
study pathogen interactions with this cell population. To address this need, in the first 
phase of the work a comparison of commonly described methods to in vitro generate 
moM was performed: addition of porcine plasma (10 or 20 or 30 % v/v) or hM-
CSF (50 or 100 or 200 ng/ml). 
Clear phenotypic differences between moMΦ produced under the different 
conditions were found. moM generated using autologous plasma presented 
increased granularity compared to those differentiated using hM-CSF, as estimated 
by their SSC properties in flow cytometry analysis, particularly evident when using 
plasma concentrations of 30%. moM generated with porcine plasma displayed a 
more elongated phenotype and, as already noted by other authors (Sànchez et al., 
1999), were characterized by the presence of numerous cytoplasmic projections. 
Using autologous plasma, a greater inter-animal variability was observed, whereas 
the use of hM-CSF produced macrophage populations characterized by phenotypic 
homogeneity. Differentiation of monocytes into macrophages is accompanied by the 
acquisition of new cell surface antigens, whose detection has been widely employed 
to identify different maturation stages within the monocyte/macrophage lineage. In 
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particular the expression of CD163 (Sanchez et al, 1999), a 120kD single pass type 1 
transmembrane cell surface glycoprotein, and CD203a, previously clustered as SWC 
9 (Dominguez et al., 1998), helps to identify mature macrophages (Sánchez-Torres et 
al., 2003). Previous studies reported that CD163, CD203a and MHC II-DR are up-
regulated during in vitro MoMΦ differentiation (Kristiansen et al., 2001, Chamorro 
et al., 2004, Wang et al., 2011) and we observed up-regulation of these surface 
markers with each of the protocols tested. Nevertheless, the use of higher 
concentrations of porcine plasma led to a reduced expression of CD163, whereas no 
significant differences were observed in the levels of CD203a and MHC II-DR 
between moMΦ populations. A pronounced individual variability in terms of cell 
surface markers expression, especially evident when analysing CD163 expression, 
was observed in moM differentiated using porcine autologous plasma. These 
results suggest that hM-CSF is able to promote the production of a more 
homogeneous cell population. 
Addition of plasma or hM-CSF was able to promote porcine monocyte/macrophage 
survival in culture, as previously reported by other authors (Wang et al., 2011). A 
lower number of metabolically active cells were detected when cells were grown in 
monocyte medium (RPMI + antibiotics + 10% FSB) alone rather than in media 
supplemented with porcine plasma or h-MCSF. Supplementation with hM-CSF 
resulted in a higher number of metabolically active cells, particularly evident using 
the highest concentration tested (200ng/ml). These results are in accordance with 
previous publications, where the mitogen activity of hM-CSF for porcine monocytes 
was described (Fairbairn et al., 2013). Monocytes cultured in un-supplemented 
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serum-free RPMI did not survive, as previously reported in humans (Becker et al., 
1897) and pigs (Basta et al., 1999). 
Then the susceptibility of moMΦ differentiated with different techniques to ASFV 
infection was assessed, analysing the intracellular levels of the late ASFV p72 
protein. Using flow cytometry, it was evaluated if the differentiation method 
influenced viral tropism. In accordance with previous publications, moMΦ were 
more susceptible to ASFV infection than freshly isolated monocytes (Basta et al., 
1999, McCullough et al., 1999, Sanchez-Torres et al., 2003), but moMΦ showed 
similar permissiveness to ASFV infection notwithstanding the different media in 
which they were grown. MoMΦ differentiation was also assessed by analysing TNF-
 release in response to LPS (Gessani et al., 1993). Previous work reported that 
moM released high levels of this cytokine in response to LPS stimulation with no 
differences between various pig breeds (Kapetanovic et al., 2013). In our study 
macrophages differentiated using all 6 protocols released higher levels of TNF- 
than freshly isolated monocytes, suggesting that with all the methods cells acquire a 
macrophage-like functionality. Differences were detected between different 
concentrations of porcine plasma (10 vs 20 vs 30%) and hM-CSF (50 and 100 vs 200 
ng/ml), nevertheless these were probably related to the higher number of viable 
moMΦ present in culture at time of stimulation.  
Then, basal release of cytokines from moMΦ populations and ability to respond to 
activation were assessed. Using different protocols, small differences were detected 
in the basal levels of IL-10 and IL-12 in culture supernatants, although IL-12 was 
also detected in the background plasma control. Despite the immunosuppressive role 
of IL-10, the levels detected were extremely low and they might not influence the in 
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vitro responses of macrophages to external stimuli. In fact, moM differentiated 
using hM-CSF responded efficiently to classical activation. Greater differences were 
detected in the levels of IL-1RA; moM differentiated using porcine plasma release 
higher levels of this cytokine although diversity amongst pigs was observed. IL-1RA, 
a member of the IL-1 family and inhibitor of the pro-inflammatory effect of IL-1 
and IL1β, is stimulated by many substances including adherent IgG, other cytokines 
and bacterial or viral component (Arend et al, 1998). In humans and mice it is 
implicated in the polarization of macrophages in moM2b, in combination with LPS, 
immune complexes and apoptotic cells (Duque et al., 2014). Our results suggest that 
some plasma components induce IL1-RA release which might affect macrophage 
phenotype and potentially skew their response to external stimuli. Few studies have 
described classical and alternatively macrophage activation in pigs (Garcia-Nicolas 
et al., 2014, Sang et al., 2014, Singleton et al., 2016). As previously stated, in pigs 
classical activation induced release of inflammatory cytokines and IL-12. In response 
to activation with IFN- and LPS, moM differentiated using hM-CSF released 
higher levels of IL-1, IL-1β and TNF- compared to those generated with 
autologous plasma and in the latter a pronounced inter-animal variability in terms of 
IL-12 was observed. Considering the important role of moM1 in host defence to 
viruses, intracellular bacteria and protozoa (Mosser and Edwards, 2008), our data 
suggest that in studies on macrophages-intracellular pathogens interactions the use of 
recombinant hM-CSF for moM generation might be the more suitable protocol. As 
previously stated, in humans exposure to IL-4 polarize cells toward an M2a 
phenotype, with production of high levels of IL-10, TGF-, IL-1RA and chemokines 
that promotes recruitment of Th2 cells (Mosser, 2003; Duque et al., 2014). In pigs, 
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independently of the protocols used to mature macrophages, no release of IL-10 or 
IL-1RA from moM2 was detected. Further studies should be performed to analyse 
alternative macrophage activation in pigs, but that was beyond the scope of the 
present work. 
In conclusion, data generated in the first phase of the work suggest that all the 
protocols tested can be considered as suitable to differentiate porcine monocytes into 
moM. However, the adoption of autologous porcine plasma, especially at high 
concentrations, yielded to a pronounced cell pleomorphism and the use of 30% of 
porcine plasma produced moM with basal release of IL-1RA, reduced expression 
of CD163, and lower ability to respond to classical activation, suggesting that these 
cells are developing toward a M2b-like phenotype. Instead supplementation with 
hM-CSF produced macrophage populations characterized by phenotypic and 
functional homogeneity, provided a better reproducibility between experiments and a 
slightly higher responsiveness to M1 polarization, even if a little but statistically 
significant basal release of IL-10 was detected. Nevertheless, the higher proliferation 
rate found in macrophages cultured in media supplemented with high concentration 
of hM-CSF could impair in vitro study where a constant number of cells is required. 
The information generated suggested the adoption of low concentration of hM-CSF 
for porcine moM generation, so in the second part of the work moM were 
generated using 50 ng/ml of hM-CSF. 
The second phase of the work aimed to provide a better understanding of the 
interaction of monocytes and derived macrophage subsets with ASFV. We consider 
crucial to better caracterise the interaction of ASFV with the porcine immune system, 
and its target cells in particular, in order to generate information useful to underpin 
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vaccine development efforts. An efficient vaccine against ASFV would be an 
important tool to fight this disease, which is now threatening the pig industry in 
Russia and Europe. 
Differences in the expression of functional surface markers and cytokine release on 
monocytes and derived macrophage subsets after in vitro infection with ASFV 
isolates of differing virulence was performed. Few studies have described classical 
and alternatively macrophage activation in pigs (Singleton et al., 2016, Garcia-
Nicolas et al., 2014, Sang et al., 2014) and no investigation of the interaction of 
ASFV with activated macrophage subsets was conducted.  As previously stated, 
macrophages in antithetic polarize status might react differently to ASFV infection, 
with differences between isolates of diverse virulence, influencing the development 
of disease rather than acquisition of protective immunity.  
First, the susceptibility of monocytes and derived macrophage subsets to ASFV 
infection was determined. Differentiation of monocytes into macrophages resulted in 
an increased susceptibility to ASFV infection, in accordance with previous 
publications (Sánchez-Torres et al., 2013, McCullough et al., 1999, Basta et al., 
1999). 22653/14 displayed greater ability to infect monocytes than the avirulent 
BA71V, with differences in the levels of late (p72) but not early (p30) proteins. 
These results suggest that BA71V replication in these cells is inhibited in the early 
stage of replication, whereas the virulent isolate has developed mechanisms to 
promote its growth in monocytes, which in vivo probably results in its ability to 
disseminate in the host. 22653/14 presented also greater ability to infect moM1 than 
the avirulent strain and pre-treatment of porcine macrophages with IFN- or LPS 
alone resulted in an increased resistance to BA71V but not 22653/14 infection. Also 
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a previous study reported that IFN- reduced ASFV replication in porcine monocytes 
and alveolar macrophages, with inhibition of expression of late (p220 and p72) but 
not early (p27) proteins (Esparza et al., 1988). The authors did not observe 
differences in the anti-viral potencies of type II IFN between a virulent (CC83) and 
an avirulent (BA71V) strains, whereas our data revealed differences between strains 
varying in virulence. A recent study reported similar results in the sensitivity of 
ASFV strains to another IFN: IFN-α. Pre-treatment with IFN-α of alveolar 
macrophages reduced replication of attenuated isolates containing MGF 360/530 
deletions but not virulent ASFV strains (Golding et al., 2016). BA71V and other 
attenuated strains present deletions in the region containing 360/530 MGFs (Zsak et 
al., 2001), which suppress type I IFN responses (Afonso et al., 2004, Correia et al., 
2013) and might also interfere with antiviral genes induced by type II IFN. Our data 
also showed that pre-treatment of porcine macrophages with LPS alone resulted in an 
increased resistance to BA71V-infection. Pre-treatment of macrophages with LPS 
can affect macrophage phagocytotic activity, and thus susceptibility to ASFV 
infection (Basta et al., 2001), but differences were observed between the avirulent 
BA71V and the virulent 22653/14 strains. It may be hypothesised that LPS 
engagement with TLR4 leads to IFN- expression (Malmgaard, 2014), inducing an 
antiviral state whose effects are significantly stronger against the avirulent isolate. 
Both isolates were able to infect moM2, without statistically significant differences 
using an MOI of 1. Similar results were observed in the other two studies on 
activated monocyte-derived macrophages: IFN- activation almost completely 
prevented moM infection by a low virulent PRRSV, but not or only partially to 
virulent field isolates (Garcia-Nicolas et al., 2014), whereas M2 polarization did not 
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interfere with PRRSV replication (Singleton et al., 2016, Garcia-Nicolas et al., 
2014).  
Using an MOI of 0.01, the ability of the two ASFV strains to grow in macrophage 
subsets was evaluated. Macrophage activation, especially classical, resulted in an 
initial reduction of 22653/14 replication; nevertheless 48 hours pi almost all (>90%) 
of the live moM1 and moM2 were p30+/p72+ and no differences between 
macrophage subsets were observed in the levels of viral copies number at any time 
points, suggesting that activation only delayed and did not inhibit 22653/14 
replication in these cells. Interestingly, using an MOI of 0.01 only little levels of 
ASFV viral proteins were detected after BA71V-infection. Probably using a low 
MOI the replication of the avirulent strain in macrophages is inhibited soon after 
infection, before the synthesis of early viral proteins, whereas after high MOI 
infection BA71V is able to perform initial stages of replication, but then infected 
cells undergo apoptosis, preventing the production of infectious viral progeny. Little 
but statistically significant differences were observed between macrophage subsets in 
the intracellular levels of ASFV proteins 24 hours pi with the avirulent strain. moM2 
display higher permissiveness to BA71V-infection that moM and moM1, 
suggesting that alternative macrophage activation is negatively correlated with ASFV 
resistance.  
The effect of ASFV-infection on cell surface markers was next investigated. In 
accordance with previous publication, our results showed that ASFV down-regulates 
CD16 expression on monocytes and macrophages (Sanchez-Torres et al., 2003, 
Lithgow et al., 2014). CD16 is a low-affinity receptor for the IgG Fc, that mediates 
phagocytosis and antibody-dependent cellular cytotoxicity (Dato et al., 1992). Both 
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isolates down-regulated the expression of this marker, so this effect has not been lost 
during BA71V attenuation. Our data suggested that down-regulation is a direct 
consequence of ASFV infection and occurs after late protein synthesis. Down-
regulation of CD16 could impact the function of infected cells and ASFV might 
modulate the expression of surface markers on these cells in order to reduce their 
anti-microbial/viral activity, promoting the distribution of cellular sources to 
synthesize new viral proteins. The effect of ASFV on MHC class I and II expression 
was assessed. MHC II present antigenic peptides to CD4 T cells, whereas CD8 T 
cells recognize antigens presented by MHC I (Trombetta and Mellman, 2005), so 
modulation of their expression can thus affect antigen presentation and development 
of adaptive immune responses.  
22653/14-infected monocytes/macrophages presented similar MHC-I levels to 
bystander or mock-infected cells, instead BA71V-infected moM and moM2 
displayed a lower percentage of MHC I+ cells than uninfected cells. This down-
regulation might be due to a general blockade of the protein synthesis, a consequence 
of pro-apoptotic signals that occurs after infection with the avirulent strain, or by 
other mechanisms commonly used by viruses to inhibit MHC class I expression, such 
as cellular transport inhibition or active removal from the cell surface (Tortorella et 
al., 2000). In a previous study ASFV infection was associated with down-regulation 
of IFN-α-induced MHC class I expression on aortic endothelial cells, where 
activation of the apoptotic pathway occurred rapidly after infection (Valee et al., 
2001). Probably in the absence of the mechanisms developed by virulent ASFV 
strains to survive in myeloid cells, ASFV-infected cells undergo apoptosis and down-
regulate MHC class I, activating NK cell killing (Lanier, 2005). Another hypothesis 
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might be that infection with BA71V and not with 22653/14 leads to a higher release 
of some IFN- subtypes, with inhibitory action on MHC class I expression. Even if 
the release of type I IFN in response to ASFV infection was not assessed, a previous 
study reported that a low virulent ASFV isolate induced enhanced expression of IFN-
than virulent one (Gil et al., 2008) and some IFN- subtypes have shown 
inhibitory control on MHC I expression on porcine cells (Zanotti et al., 2015). The 
absence of MHC class I down-regulation in moM1 might be due to the fact that viral 
replication is inhibited soon after infection, so the signals that induce MHC class I 
down-regulation in BA71V-infected moM do not occur. Extremely little 
differences were observed in the MHC-II expression of monocytes/macrophages, 
suggesting that ASFV does not modulate the expression of this marker, as previously 
described for monocytes, alveolar (Sánchez-Torres et al., 2003) and bone marrow 
derived macrophages (Lithgow et al., 2014). Finally, we analysed the effect of ASFV 
on CD163. A role of this molecule in the process of infection of porcine 
monocytes/macrophages by ASFV has been suggested, but a recent study suggested 
that this marker was not essential in ASFV infection (Sánchez-Torres et al., 2013, 
Lithgow et al., 2014). Using p72 mAb to determine the intracellular levels of ASFV, 
infected monocytes/macrophages expressed similar percentage of CD163 to 
bystander cells, supporting the results of Lithgow et al. (2014). Levels of CD163 on 
BA71V-infected cells were always lower than the mock-infected control, perhaps 
because its synthesis was inhibited, as a consequence of pro-apoptotic signals, or 
because its extracellular portion was released after infection, in response to 
inflammatory or other stimuli (Ezquerra et al., 2009). 
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In the final part of the study the cytokine responses of porcine 
monocyte/macrophages to ASFV infection were characterised. Previous studies 
reported that macrophage infection with ASFV resulted in an enhanced expression of 
mRNA levels of pro-inflammatory cytokines (TNF-, IL-1, IL-6, IL-15) (Gómez 
del Moral et al., 1999, Gil et al., 2003, Zhang et al. 2006), with differences between 
isolates of different virulence (Gil et al., 2008). Contrasting results were reported on 
the levels of TNF- in culture supernatants: Gomez del Moral et al. (1999) observed 
an increased in the levels of this cytokine in culture supernatant after infection with 
the virulent E-75, instead Zhang et al. (2006) could not detect it, despite the increase 
of its mRNA in the cells soon after infection with the virulent Malawi LIL120/1 and 
the low virulent OURT88/3. Authors speculated that post-transcriptional events 
involved in protein stability could affect the levels of the protein accumulated. In 
accordance to the latter study no TNF- release in response to ASFV infection was 
detected in our work. These differences might be related to the different strains 
adopted. In accordance with Zhang et al. (2008) IL-1release was observed in 
response to ASFV infection, but we observed higher IL-1 levels from 
monocytes/activated macrophages mainly in response to the avirulent BA71V strain. 
Also higher levels of IL-1 were detected after BA71V infection in comparison to 
the virulent 22653/14. Both IL-1 and IL-1 are strongly pro-inflammatory 
cytokines and perform their functions through binding of the IL-1 receptor (IL-1R) 
(Duque and Descoteaox, 2014). IL-1 is synthesized as a biologically inactive 
precursor inside the cell and it is cleaved by the enzyme caspase-1 to the biologically 
active mature form that is released from cells (Arend et al., 2008). IL-1 has a pro-
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apoptotic role (Friedlander et al., 1996), so it could be speculated that the release of 
IL-1 after BA71V infection may contribute to the early apoptosis of porcine 
monocyte/macrophages, which in vivo probably limits viral replication and pro-
inflammatory dysregulation. The virulent 22653/14 might have developed 
mechanism to inhibit IL-1 release, in order to promote its replication inside 
monocyte/macrophages. Gil et al. (2008) reported an increase of the IL-12p40 levels 
in  macrophage supernatants after ASFV infection, with differences between isolates 
of different virulence (Gil et al., 2008). IL-12 release after ASFV infection of 
monocytes/macrophage subsets was not detected in our experiments, and this 
difference might due to the fact that an avirulent (BA71V) and not a low virulent 
(NH/P68) isolate was tested, or because IL-12p40 is also a subunit of IL-23 
(Oppmann et al., 2000), which might be released in response to infection with low 
virulent ASFV strains. Nevertheless, an increase in the levels of another potent IFN- 
inducer was detected in the supernatants of BA71V infected macrophages: IL-18 
(Dinarello, 1999). This cytokine is a member of the IL-1 family and, like IL-1, is 
synthesized as a inactive precursor molecule which is cleaved by caspase-1 before or 
during the released from cells (Dinarello, 1999; Arend et al., 2008). IL-18 synergizes 
with IL-12 to promote the development of a TH1 response and it activates T cells to 
synthesize IL-2, IFN- and TNF- (Dinarello, 1999). Release of IL-18 may be 
implicated in the acquisition of a TH1 cell response, correlated to protection against 
ASFV (Takamatsu et al., 2013), and the difference observed between isolates of 
different virulence might suggest that 22653/14 have developed mechanism to 
counteract the induction of this response.   
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In summary, our detailed in vitro analysis of the interaction of ASFV isolates varying 
in virulence with monocytes and derived macrophage subsets revealed that compared 
to the avirulent BA71V strain, the field isolate 22653/14 showed an enhanced 
capacity to replicate in monocytes and moM1, did not induced MHC I down-
regulation in infected moM/moM2 and induced lower release of IL-18, IL-1and 
IL-1. It is hoped that the observed strains differences will be valuable to aid our 
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